Other disorders of breast

N14_BREASTDISOTH

breast disease: A disease involving the breast.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N64 Hospital discharge: ICD-9 — 611[2-9] Hospital discharge: ICD-8 — 611[2-9] Hospital discharge: excluded ICD-9 — 6117B Cause of death: ICD-10 — N64 Cause of death: ICD-9 — 611[2-9] Cause of death: ICD-8 — 611[2-9] Cause of death: excluded ICD-9 — 6117B 2 out of 7 registries used, show all original rules.	6718
4. Check minimum number of events None	6718
5. Include endpoints N14_GALACTORRHEA	6761
6. Filter based on genotype QC (FinnGen only)	6105

Control definitions (FinnGen only)

Control exclude: N14_BREAST

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N60-N64
Name in latin: Aliae morbositates mammae

NAME	N14_BREASTDISOTH
CONTROL_EXCLUDE	N14_BREAST
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	N14_GALACTORRHEA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N64
HD_ICD_9	611[2-9]
HD_ICD_8	611[2-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	6117B
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N64
COD_ICD_9	611[2-9]
COD_ICD_8	611[2-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	6117B
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Galactorrhea

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30304	30304	-
Only index persons	28891	28891	-
Unadjusted period prevalence (%)
Whole population	0.87	0.87	-
Only index persons	1.06	1.06	-
Median age at first event (years)
Whole population	-	45.19	-
Only index persons	-	44.88	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6105	6105	-
Unadjusted period prevalence (%)	2.17	2.17	-
Median age at first event (years)	49.02	49.02	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6375: Matched controls
63750

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N64.4

ICD-10 Finland

Mastodynia

14.2

307.7

1528

1382

D24

ICD-10 Finland

Benign neoplasm of breast

8.6

307.7

432

537

N64.9

ICD-10 Finland

Disorder of breast, unspecified

112.3

307.7

1278

142

N64.8

ICD-10 Finland

Other specified disorders of breast

67.4

307.7

588

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

8.4

307.7

1884

3046

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

10.3

307.7

409

423

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

51.6

307.7

393

HA1AA

NOMESCO Finland

X-ray mammography

4.4

307.7

1378

3773

N62

ICD-10 Finland

Hypertrophy of breast

64.4

307.7

410

HA5CB

NOMESCO Finland

Galactography

174.7

307.7

203

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.3

307.7

513

755

N64.5

ICD-10 Finland

Other signs and symptoms in breast

84.0

307.7

2701

553

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

8.2

307.7

710

961

N63

ICD-10 Finland

Unspecified lump in breast

7.0

307.7

1276

2194

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

18.2

307.7

659

402

HAB99

NOMESCO Finland

Other partial excision of mammary gland

7.6

307.7

503

713

N61

ICD-10 Finland

Inflammatory disorders of breast

7.5

297.1

441

625

9729

FHL

Other measure in this category

74.1

282.3

152

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

7.9

277.8

391

521

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

21.8

275.5

205

HAB20

NOMESCO Finland

Excision of lactiferous duct

354.6

240.0

241

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

11.2

230.9

246

227

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

4.2

203.6

589

1521

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

6.0

201.0

369

649

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

18.6

195.7

156

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

14.6

190.5

172

121

X21

ICPC

Breast sympt/compl female other

5.1

179.3

391

804

61199

ICD-8 Finland

Other diseases of breast, Other

+∞

167.4

160

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.4

165.8

663

2125

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

25.9

161.4

112

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

22.4

147.3

108

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

219.4

145.6

150

HAE99

NOMESCO Finland

Other reconstruction of breast

9.3

143.1

173

190

HA1AE, ,

SPAT

3.5

143.0

527

1599

N64.2

ICD-10 Finland

Atrophy of breast

283.4

135.8

138

6114A

ICD-9 Finland

Other disorders of breast, Atrophy of breast

+∞

133.8

128

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

4.7

132.1

314

692

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

6.2

124.3

217

362

HA1RA, ,

SPAT

2.9

123.3

641

2378

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

18.5

119.4

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

3.8

118.4

379

1044

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.6

118.4

228

418

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

4.8

112.4

258

552

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

6.2

111.5

192

316

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

4.6

110.1

272

618

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

5.7

109.8

207

372

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.7

106.7

630

2492

HAD40

NOMESCO Finland

Mastopexy

8.9

105.7

132

151

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

4.9

105.1

239

507

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

5.2

103.3

218

434

N60.0

ICD-10 Finland

Solitary cyst of breast

13.7

103.2

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

10.7

103.1

112

106

PJA12

NOMESCO Finland

Sentinel node biopsy

2.4

101.3

812

3705

HAC20

NOMESCO Finland

Total mastectomy

3.1

97.9

445

1527

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

95.0

1527

9043

9702

FHL

Breast exploration and possible tumor removal

7.3

94.7

140

196

N60.2

ICD-10 Finland

Fibroadenosis of breast

13.0

93.9

Q83.8

ICD-10 Finland

Other congenital malformations of breast

14.5

92.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

13.2

89.6

N64

ICD-10 Finland

Other disorders of breast

11.9

85.9

61191

ICD-8 Finland

Other diseases of breast, Fibrosis mammae

+∞

82.5

115

Kela drug reimbursment

Breast cancer

2.2

81.6

821

4095

HAD99

NOMESCO Finland

Other plastic operation on breast

7.8

80.2

111

144

N60.8

ICD-10 Finland

Other benign mammary dysplasias

207.6

79.4

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.0

78.2

119

172

C50.99

ICD-10 Finland

Breast, unspecified

3.3

78.1

311

985

J02AC01

ATC

fluconazole; systemic

1.6

78.0

3406

26280

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.2

78.0

134

220

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.6

77.8

472

1884

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

76.4

2732

20026

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

38.6

74.7

TQW20

NOMESCO Finland

Tatoe

5.1

71.8

153

307

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

6.1

71.4

125

209

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

69.8

2046

14185

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

8.0

67.6

117

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

8.5

67.3

104

HAA10

NOMESCO Finland

Biopsy of mammary gland

7.4

67.2

135

N60.4

ICD-10 Finland

Mammary duct ectasia

171.8

65.1

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

8.6

64.8

J01DB01

ATC

cefalexin; oral

1.8

64.8

5368

47510

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

22.5

64.2

61198

ICD-8 Finland

Other diseases of breast, Alii definita

+∞

63.6

X18

ICPC

Breast pain female

3.6

63.3

217

624

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

3.1

62.3

273

914

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

23.3

60.9

C50

ICD-10 Finland

Malignant neoplasm of breast

3.0

59.3

273

940

X19

ICPC

Breast lump/mass female

3.2

56.5

229

732

9703

FHL

Breast resection

6.6

56.4

140

N64.0

ICD-10 Finland

Fissure and fistula of nipple

88.0

54.9

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.5

54.7

346

1405

HAD00

NOMESCO Finland

Augmentation mammoplasty

15.4

52.8

N64.1

ICD-10 Finland

Fat necrosis of breast

+∞

52.1

ZZR10

NOMESCO Finland

Flap of skin and muscle

5.4

52.0

102

190

A02BC02

ATC

pantoprazole; systemic

1.5

51.7

4331

37026

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

6.6

51.3

125

A02BC05

ATC

esomeprazole; systemic

1.5

51.1

2630

20340

QBJ00

NOMESCO Finland

Liposuction in trunk

6.5

50.6

130

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

10.1

50.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

50.3

1764

12560

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

7.5

49.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

49.4

2292

17320

6118X

ICD-9 Finland

Other disorders of breast, Other specified disorders of breast

+∞

49.0

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.2

48.7

132

322

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2.2

48.5

443

2111

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

48.1

1647

11644

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

3.1

47.6

198

643

6119X

ICD-9 Finland

Other disorders of breast, Unspecified breast disorder

+∞

46.9

R51.80

ICD-10 Finland

Headache

1.6

46.3

1207

7993

C07AA05

ATC

propranolol; systemic

1.6

46.0

1453

10072

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

45.9

L02BA01

ATC

tamoxifen; oral

2.3

45.8

373

1696

N02AX02

ATC

tramadol; systemic, rectal

1.5

45.7

2468

19143

ZXA05

NOMESCO Finland

Left side

1.6

44.2

1328

9088

61190

ICD-8 Finland

Other diseases of breast, Atrophia mammae

+∞

43.8

M03BX02

ATC

tizanidine; oral

1.5

43.0

4091

35137

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

41.4

241

939

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

40.8

2065

15723

J01FA10

ATC

azithromycin; systemic

1.4

40.8

3923

33588

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

5.8

40.6

129

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.9

40.4

199

711

P01AB01

ATC

metronidazole; oral, rectal

1.4

40.0

2802

22632

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

39.6

584

3290

M79.6

ICD-10 Finland

Pain in limb

1.4

39.3

2977

24357

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

38.7

1503

10836

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

38.3

1451

10405

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

37.7

881

5651

N03AX16

ATC

[U] pregabalin

1.5

37.5

1381

9837

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.2

37.4

153

492

E0000UV, ,

ATC

1.4

36.9

2757

22414

N02BE01

ATC

paracetamol; systemic, rectal

1.7

36.2

5708

53177

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

36.1

1671

12445

N05BA04

ATC

oxazepam; oral

1.5

36.1

1722

12902

N76.0

ICD-10 Finland

Acute vaginitis

1.8

36.1

640

3808

K30

ICD-10 Finland

Functional dyspepsia

1.7

35.8

823

5252

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

35.7

407

2103

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.0

35.7

160

543

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

35.6

3874

33475

M25.5

ICD-10 Finland

Pain in joint

1.4

35.4

2290

18123

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

4.9

35.0

159

G44.2

ICD-10 Finland

Tension-type headache

1.6

34.9

1041

7069

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

34.0

2024

15756

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.5

33.7

209

840

Z71.8

ICD-10 Finland

Other specified counselling

1.4

33.5

2302

18358

E22.1

ICD-10 Finland

Hyperprolactinaemia

4.0

33.4

245

61000

ICD-8 Finland

Chronic cystic disease of breast, Fibroadenomatosis mammae

+∞

33.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

33.2

687

4262

Z2221

NOMESCO Finland

Medical doctor

1.4

33.1

1701

12885

L02BG04

ATC

letrozole; oral

1.7

33.0

610

3668

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

32.9

1109

7724

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

32.9

1387

10115

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

32.8

1249

8924

ZXA00

NOMESCO Finland

Right side

1.5

32.7

1371

9988

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

6.2

32.5

61099

ICD-8 Finland

Chronic cystic disease of breast, Unspecified

+∞

32.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

31.8

638

3923

J01DA01

ATC

[U] cefalexin

1.4

31.7

3805

33083

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

31.5

2157

17143

J01AA02

ATC

doxycycline; systemic

1.4

31.4

4857

44021

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

31.1

1148

8142

R07.3

ICD-10 Finland

Other chest pain

1.7

30.8

628

3875

R06.0

ICD-10 Finland

Dyspnoea

1.4

30.8

1551

11676

J01MA02

ATC

ciprofloxacin; systemic

1.4

30.7

2042

16137

HAD20

NOMESCO Finland

Liposuction of breast

10.4

30.7

HA1AA, ,

SPAT

2.3

30.5

227

992

S18

ICPC

Laceration/cut

1.4

30.4

2640

21769

D22

ICD-10 Finland

Melanocytic naevi

1.9

30.3

427

2368

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

+∞

30.2

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

+∞

30.2

M54.5

ICD-10 Finland

Low back pain

1.4

29.8

2407

19600

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

29.7

619

3841

M79.1

ICD-10 Finland

Myalgia

1.5

29.5

1047

7357

M01AE02

ATC

naproxen; oral, rectal

1.4

29.4

3617

31386

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.4

29.3

207

884

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

5.3

29.1

110

X76

ICPC

Malignant neoplasm breast female

2.5

29.1

185

753

ZXD20

NOMESCO Finland

Day surgery

1.6

29.1

771

5079

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

28.9

3282

28104

M01AH05

ATC

etoricoxib; oral

1.4

28.8

3950

34794

J02AC02

ATC

itraconazole; systemic

1.5

28.7

1153

8305

A02BC01

ATC

omeprazole; systemic

1.4

28.6

1579

12059

R52.9

ICD-10 Finland

Pain, unspecified

1.6

28.5

677

4341

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

28.5

859

5824

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

28.5

1088

7755

A02BC04

ATC

rabeprazole; oral

1.7

28.5

586

3624

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

28.3

422

2381

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

28.0

3522

30559

J01FF01

ATC

clindamycin; systemic

1.4

28.0

1547

11811

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

27.7

2421

19891

R01AD08

ATC

fluticasone; nasal

1.4

27.7

1865

14710

R4110

NOMESCO Finland

Physiotherapy

1.4

27.4

1562

11981

R03AC02

ATC

salbutamol; inhalant

1.3

27.2

3554

30945

R01AD09

ATC

mometasone; nasal

1.3

27.2

3039

25866

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

26.9

1366

10262

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

26.8

358

1950

XX2XW

NOMESCO Finland

Other teleradiological consultation

5.3

26.8

100

ZXA10

NOMESCO Finland

Bilateral

1.5

26.7

973

6861

R53

ICD-10 Finland

Malaise and fatigue

1.4

26.7

1606

12421

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

26.7

641

4120

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

3.2

26.5

107

342

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

26.5

901

6263

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

26.5

1864

14787

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

5.3

26.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

5.8

26.3

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

6.0

25.9

N06AB04

ATC

citalopram; systemic

1.4

25.9

1302

9757

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

25.8

2259

18506

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

4.2

25.8

163

A02BC03

ATC

lansoprazole; oral

1.4

25.8

1597

12397

R00.2

ICD-10 Finland

Palpitations

1.6

25.7

587

3724

J01CA08

ATC

pivmecillinam; oral

1.3

25.5

3431

29874

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.7

25.5

137

514

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

25.5

2576

21542

O92.6

ICD-10 Finland

Galactorrhoea

7.3

25.4

N05CD07

ATC

temazepam; oral

1.7

25.1

545

3413

L03

ICPC

Low back symptom/complaint

1.4

25.0

1950

15688

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

24.9

2739

23154

G01AA10

ATC

clindamycin; vaginal

1.4

24.9

1244

9302

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.6

24.9

142

549

N06AX11

ATC

mirtazapine; oral

1.3

24.8

2113

17215

L01

ICPC

Neck symptom/complaint

1.4

24.7

1146

8453

R01AD58

ATC

fluticasone, combinations; nasal

1.4

24.5

1756

13931

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

24.5

1315

9952

J01MA12

ATC

levofloxacin; systemic

1.5

24.1

881

6208

J01FA09

ATC

clarithromycin; systemic

1.3

24.1

1966

15904

S04

ICPC

Lump/swelling localized

1.5

24.0

711

4793

N05BA12

ATC

alprazolam; oral

1.6

24.0

600

3891

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

6.4

23.9

UJF32

NOMESCO Finland

Coloscopy

1.4

23.8

1382

10594

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

23.7

553

3525

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

23.6

577

3720

A02BA02

ATC

ranitidine; systemic

1.5

23.4

983

7113

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

4.9

23.4

105

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

23.0

237

1181

N05CF01

ATC

zopiclone; oral

1.3

23.0

1772

14192

G02CB01

ATC

bromocriptine; systemic

2.4

22.8

160

682

R05

ICD-10 Finland

Cough

1.4

22.8

1343

10310

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.5

22.6

680

4598

UKC02

NOMESCO Finland

Cystoscopy

1.6

22.5

550

3545

L04

ICPC

Chest symptom/complaint

1.7

22.2

412

2474

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

22.1

2413

20268

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.1

22.0

296

N06AX16

ATC

venlafaxine; oral

1.4

22.0

955

6948

N06AX21

ATC

duloxetine; oral

1.5

21.9

791

5554

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

21.8

1509

11869

D01

ICPC

Abdominal pain/cramps general

1.5

21.6

846

6032

Z3226

NOMESCO Finland

Physiotherapist

1.4

21.6

965

7057

GD1AA, ,

SPAT

1.4

21.5

1011

7458

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

21.5

1160

8767

R01AD12

ATC

fluticasone furoate; nasal

1.3

21.4

2123

17583

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

21.3

791

5583

D07AD01

ATC

clobetasol; topical

1.4

21.2

1037

7704

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

21.2

208

1019

K07.60

ICD-10 Finland

Snapping jaw

1.7

21.0

408

2480

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

20.9

363

2139

9722

FHL

Reduction plastic and possible mamilla transposition

28.1

20.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

20.8

2512

21338

HA1SA

NOMESCO Finland

Expansion mammography

4.4

20.8

116

XQ800

NOMESCO Finland

Prick test

1.6

20.7

512

3308

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

20.6

477

3032

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

20.6

304

1708

N03AX12

ATC

[U] gabapentin; oral

1.4

20.5

908

6624

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

20.5

1105

8343

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

20.4

804

5735

M01AB05

ATC

diclofenac; systemic, rectal

1.3

20.4

3951

35587

R42

ICD-10 Finland

Dizziness and giddiness

1.4

20.3

1327

10329

V500A

ICD-9 Finland

Elective surgery for purposes other than remedying health states, Hair transplant

6.1

20.3

HAA00

NOMESCO Finland

Incision of mammary gland

48.2

20.1

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

3.1

20.1

280

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

7.6

19.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

19.9

442

2783

G02CB03

ATC

cabergoline; oral

4.1

19.8

133

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

19.8

528

3471

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

19.8

600

4058

Z00.0

ICD-10 Finland

General medical examination

1.4

19.8

1057

7964

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.6

19.7

174

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

19.6

1390

10947

WX402

NOMESCO Finland

General anaesthesia

1.4

19.6

1294

10081

R83

ICPC

Respiratory infection other

1.3

19.6

1740

14159

HA5CB, ,

SPAT

105.4

19.6

N60.3

ICD-10 Finland

Fibrosclerosis of breast

200.6

19.6

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

19.5

494

3208

D05.0

ICD-10 Finland

Lobular carcinoma in situ

7.1

19.5

Z01.7

ICD-10 Finland

Laboratory examination

1.4

19.4

1014

7610

Z31.5

ICD-10 Finland

Genetic counselling

1.7

19.3

395

2433

N06AB10

ATC

escitalopram; oral

1.3

19.2

1353

10644

N05BA01

ATC

diazepam; systemic, rectal

1.5

19.2

687

4810

X58

ICD-10 Finland

Exposure to other specified factors

1.4

19.1

797

5747

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

19.1

512

3371

HA1HA

NOMESCO Finland

Tomosynthesis mammography

3.3

19.1

217

D07AC01

ATC

betamethasone; topical

1.3

19.0

2098

17553

S29

ICPC

Skin symptom/complaint other

1.4

19.0

1212

9387

THA00

NOMESCO Finland

Needle biopsy of mamilla

20.1

19.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

19.0

324

1901

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

18.9

654

4547

J05AB11

ATC

valaciclovir; oral

1.4

18.9

937

6967

K59.0

ICD-10 Finland

Constipation

1.7

18.7

316

1849

C07AB07

ATC

bisoprolol; oral

1.3

18.7

2308

19581

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

18.7

765

5495

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

18.6

243

1314

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

18.6

242

1307

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

18.6

166

784

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.5

18.6

118

482

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

38.5

18.5

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

18.5

5746

54888

G03DB01

ATC

dydrogesterone; oral

1.4

18.4

1048

7968

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

18.2

232

1246

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

3.6

18.1

170

H02AB06

ATC

prednisolone; systemic

1.3

18.1

2732

23721

N05CF02

ATC

zolpidem; oral

1.4

17.9

1058

8087

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

4.7

17.9

M03AX01

ATC

botulinum toxin; parenteral

2.4

17.9

119

496

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2.5

17.8

112

455

X26

ICPC

Fear of breast cancer female

3.2

17.8

211

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

17.8

537

3625

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

17.8

486

3210

Z3231

NOMESCO Finland

Registered nurse

1.3

17.8

1379

10982

R06AE07

ATC

cetirizine; oral

1.3

17.8

2908

25468

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

17.8

439

2835

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

17.6

1297

10250

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

17.6

528

3562

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

17.6

1862

15464

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

17.5

604

4192

J01FA06

ATC

roxithromycin; oral

1.3

17.5

2333

19932

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

17.5

776

5653

9724

FHL

Breast augmentation or reconstruction with own tissue

15.6

17.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

17.4

503

3364

Q83.1

ICD-10 Finland

Accessory breast

5.9

17.4

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

17.4

717

5152

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

17.3

952

7192

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

2.4

17.3

115

480

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.5

17.3

111

456

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

17.2

397

2520

J01DA09

ATC

[U] cefadroxil

1.3

17.0

1509

12232

ZXE00

NOMESCO Finland

One hour or less

1.3

17.0

2208

18790

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

16.9

595

4146

D06

ICPC

Abdominal pain localized other

1.5

16.9

611

4281

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

3.9

16.8

123

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.2

16.8

204

D02

ICPC

Abdominal pain epigastric

1.6

16.6

418

2709

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

16.6

369

2321

B02AA02

ATC

tranexamic acid; systemic

1.3

16.6

1111

8650

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

16.6

604

4237

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

16.6

777

5711

M01AH01

ATC

celecoxib; oral

1.4

16.6

998

7647

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

16.5

204

1086

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

16.4

1100

8563

H02AB07

ATC

prednisone; oral

1.4

16.4

735

5361

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

16.3

235

1313

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

16.3

1946

16372

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

16.2

770

5671

N06AB06

ATC

sertraline; oral

1.4

16.1

721

5254

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

3.9

16.1

122

Z01.2

ICD-10 Finland

Dental examination

1.2

16.1

2998

26526

L13

ICPC

Hip symptom/complaint

1.3

16.1

1168

9198

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

16.0

1147

9019

R74

ICPC

Upper respiratory infection acute

1.3

15.9

2297

19744

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

15.9

607

4297

A03FA02

ATC

cisapride; oral, rectal

1.6

15.9

385

2474

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

15.9

627

4468

WZC30

NOMESCO Finland

Teaching

1.4

15.8

829

6207

S82

ICPC

Naevus/mole

1.4

15.8

879

6649

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

15.7

4428

40983

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

15.7

1631

13473

HA1HA, ,

SPAT

6.9

15.7

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.6

976

7513

R03DC03

ATC

montelukast; oral

1.3

15.6

1064

8298

6117E

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[RINTARAUHASEN POIKKEAVA ERITE]

+∞

15.6

K08.80

ICD-10 Finland

Toothache NOS

1.5

15.6

597

4227

X20

ICPC

Nipple symptom/complaint female

3.9

15.6

116

ZZS55

NOMESCO Finland

Distension of tissue expander

19.2

15.5

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

15.5

342

2149

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

15.4

169

864

N30.0

ICD-10 Finland

Acute cystitis

1.3

15.4

1239

9897

WX002

NOMESCO Finland

Sedation and analgesia

1.4

15.3

967

7455

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

15.2

747

5529

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

15.2

453

3050

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.0

15.2

159

799

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

15.2

675

4913

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

15.2

369

2374

C01CA24

ATC

epinephrine; parenteral

1.6

15.1

403

2647

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

15.1

332

2084

A11

ICPC

Chest pain NOS

1.5

15.1

445

2989

U07

ICPC

Urine symptom/complaint other

1.5

15.1

483

3301

N06AB03

ATC

fluoxetine; oral

1.4

15.0

732

5416

HAC25

NOMESCO Finland

Radical mastectomy

4.4

14.9

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

3.7

14.9

129

R06AX27

ATC

desloratadine; oral

1.3

14.9

1925

16304

L12

ICPC

Hand/finger symptom/complaint

1.3

14.9

1060

8315

S06.0

ICD-10 Finland

Concussion

1.5

14.9

567

4011

D19

ICPC

Teeth/gum symptom/complaint

1.3

14.9

1948

16526

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

14.9

309

1913

R03BA05

ATC

fluticasone; inhalant

1.3

14.8

1062

8337

JN1AE, ,

SPAT

1.7

14.8

262

1554

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

14.8

613

4405

L15

ICPC

Knee symptom/complaint

1.3

14.8

1528

12602

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

14.7

245

1429

N01

ICPC

Headache

1.4

14.7

758

5657

J05AB01

ATC

aciclovir; systemic

1.3

14.7

1355

11014

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

14.7

450

3049

6110A

ICD-9 Finland

Other disorders of breast, Inflammatory disease of breast

+∞

14.6

6116A

ICD-9 Finland

Other disorders of breast, Galactorrhoea not associated with childbirth

+∞

14.6

SBB10

NOMESCO Finland

Dental impressions

1.6

14.6

384

2516

M54.2

ICD-10 Finland

Cervicalgia

1.5

14.6

477

3275

HAD45

NOMESCO Finland

Eversion of mamilla

80.3

14.6

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

14.5

291

1784

R30.0

ICD-10 Finland

Dysuria

1.7

14.5

260

1548

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

4.9

14.5

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

14.5

1338

10873

R51

ICD-10 Finland

Headache

1.6

14.4

383

2514

U02

ICPC

Urinary frequency/urgency

1.3

14.4

1008

7884

R52.2

ICD-10 Finland

Other chronic pain

1.8

14.4

224

1281

Z00.8

ICD-10 Finland

Other general examinations

1.5

14.2

439

2977

J01CA04

ATC

amoxicillin; systemic

1.3

14.2

5138

48614

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.6

14.2

298

P01

ICPC

Feeling anxious/nervous/tense

1.3

14.2

894

6886

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

14.1

1644

13738

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

5.8

14.0

L03AA13

ATC

pegfilgrastim; parenteral

1.7

14.0

272

1656

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.0

563

4024

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

13.9

757

5695

L02

ICPC

Back symptom/complaint

1.4

13.9

669

4932

N06AB05

ATC

paroxetine; oral

1.6

13.9

342

2206

AA1BG, ,

SPAT

2.1

13.8

131

635

J01EA01

ATC

trimethoprim; systemic

1.3

13.8

1758

14838

XKD00

NOMESCO Finland

Uroflowmetry

1.7

13.8

229

1335

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

13.7

905

7014

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

13.7

594

4301

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

13.7

326

2088

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

13.6

786

5968

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

3.3

13.6

157

R21

ICPC

Throat symptom/complaint

1.3

13.6

1444

11925

61101

ICD-8 Finland

Other diseases of breast, Abscessus mammae

+∞

13.5

6117A

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[MASTODYNIA]

+∞

13.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

3.3

13.5

148

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

13.4

2325

20281

E000001, ,

ATC

1.3

13.4

1123

9001

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

13.4

1737

14688

L02BG06

ATC

exemestane; oral

2.0

13.3

135

671

H92.0

ICD-10 Finland

Otalgia

1.5

13.3

411

2789

J01AA07

ATC

tetracycline; systemic

1.3

13.3

895

6959

L29.2

ICD-10 Finland

Pruritus vulvae

1.9

13.2

152

791

A23

ICPC

Risk factor NOS

1.4

13.2

579

4202

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

13.2

461

3208

NA3BG, ,

SPAT

1.7

13.2

247

1490

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

13.1

128

628

R06AX22

ATC

ebastine; oral

1.3

13.1

1097

8787

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

13.1

462

3219

K04

ICPC

Palpitations/awareness of heart

1.6

13.1

330

2141

J01AA04

ATC

lymecycline; systemic

1.4

13.1

780

5952

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

12.9

325

2107

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

12.9

952

7495

HAB30

NOMESCO Finland

Excision of mamilla or areola

22.6

12.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

12.9

802

6161

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

12.9

161

862

PJW99

NOMESCO Finland

Other operation on lymphatic system

3.4

12.8

133

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

12.8

1786

15203

R07.0

ICD-10 Finland

Pain in throat

1.5

12.8

469

3292

R31

ICD-10 Finland

Unspecified haematuria

1.6

12.8

291

1843

R05

ICPC

Cough

1.3

12.7

1545

12949

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

3.7

12.7

110

H02AB04

ATC

methylprednisolone; systemic

1.3

12.7

795

6110

F29

ICPC

Eye symptom/complaint other

1.4

12.7

631

4677

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

1.8

12.6

190

1077

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

12.6

328

2143

A97

ICPC

No disease

1.3

12.6

1121

9044

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

4.6

12.6

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

2.9

12.6

197

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

12.5

369

2478

6111A

ICD-9 Finland

Other disorders of breast, Hypertrophy of breast

+∞

12.5

6117D

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[SUBINVOLUTIO MAMMAE POST PARTUM]

+∞

12.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

3.5

12.5

121

L02BG03

ATC

anastrozole; oral

2.1

12.4

110

520

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

12.4

344

2281

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

2.4

12.4

343

J01CF02

ATC

cloxacillin; systemic

2.3

12.4

424

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

12.4

517

3718

M02AA07

ATC

piroxicam; topical

1.2

12.3

1897

16308

L90.6

ICD-10 Finland

Striae atrophicae

4.5

12.3

M01AX17

ATC

nimesulide; oral

1.3

12.3

1182

9631

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.3

12.3

413

L29

ICPC

Musculoskeletal sympt/complt other

1.4

12.3

520

3750

A01

ICPC

Pain general/multiple sites

1.4

12.2

582

4283

N39.3

ICD-10 Finland

Stress incontinence

1.4

12.2

532

3858

R13

ICD-10 Finland

Dysphagia

1.5

12.1

344

2292

M79.7

ICD-10 Finland

Fibromyalgia

1.6

12.1

269

1694

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

12.1

263

1648

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

12.4

12.1

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

12.0

172

961

K80

ICPC

Cardiac arrhythmia NOS

1.4

12.0

466

3309

L17

ICPC

Foot/toe symptom/complaint

1.2

12.0

1792

15353

AA1AD

NOMESCO Finland

CT of head and brain

1.3

11.9

1305

10798

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.8

11.9

182

1038

A04

ICPC

Weakness/tiredness general

1.3

11.9

923

7313

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

11.9

210

1248

N05AH04

ATC

quetiapine; oral

1.3

11.9

969

7729

R60.0

ICD-10 Finland

Localized oedema

1.4

11.9

639

4798

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

11.8

677

5130

U01

ICPC

Dysuria/painful urination

1.4

11.8

553

4055

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

11.8

1353

11248

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

11.8

119

591

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

11.8

510

3689

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

14.7

11.8

L05

ICPC

Flank/axilla symptom/complaint

1.5

11.8

347

2332

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

11.8

890

7025

XF402

NOMESCO Finland

ECG with work load test

1.5

11.7

420

2935

G01AF05

ATC

econazole; vaginal

1.4

11.7

584

4329

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

11.7

3311

30159

R03BA02

ATC

budesonide; inhalant

1.3

11.7

1042

8406

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

11.7

2013

17489

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

11.7

383

2632

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

11.6

452

3208

L57.0

ICD-10 Finland

Actinic keratosis

1.4

11.6

442

3124

G01AF02

ATC

clotrimazole; vaginal

1.6

11.6

246

1532

A04AA01

ATC

ondansetron; systemic, rectal

1.4

11.6

468

3347

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

11.6

364

2480

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.6

11.5

264

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

11.5

703

5382

J01FA01

ATC

erythromycin; systemic

1.3

11.5

836

6564

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

11.4

219

1329

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.6

11.4

264

1679

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

11.4

1015

8185

R12

ICD-10 Finland

Heartburn

1.4

11.4

501

3638

K64.1

ICD-10 Finland

Second degree haemorrhoids

1.9

11.3

134

706

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

11.3

692

5300

N80.0

ICD-10 Finland

Endometriosis of uterus

1.8

11.2

168

952

XX2VW

NOMESCO Finland

Radiologic consultation

3.0

11.2

166

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

11.2

227

1398

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

11.2

230

1422

D23

ICD-10 Finland

Other benign neoplasms of skin

1.9

11.2

146

794

A01AB09

ATC

miconazole; local oral

1.4

11.1

456

3268

J01DA06

ATC

[U] cefuroxime

1.3

11.0

778

6078

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

1.8

11.0

158

885

A99

ICPC

Disease/condition unspecnature/site

1.4

11.0

556

4133

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

10.9

243

1532

S21

ICPC

Skin texture symptom/complaint

1.3

10.9

820

6464

G04BD08

ATC

solifenacin; oral

1.5

10.8

299

1981

G04BD12

ATC

mirabegron; oral

1.4

10.8

562

4193

N17

ICPC

Vertigo/dizziness

1.3

10.8

709

5481

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

10.8

1674

14361

G43.8

ICD-10 Finland

Other migraine

2.0

10.8

120

618

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

15.5

10.8

XQ899

NOMESCO Finland

Other assessment of skin

3.3

10.8

123

G44.0

ICD-10 Finland

Cluster headache syndrome

2.4

10.8

285

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

10.7

302

2010

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

2.7

10.7

198

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

10.7

360

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

10.7

2057

18026

G01AF01

ATC

metronidazole; vaginal

1.3

10.7

685

5279

K58

ICD-10 Finland

Irritable bowel syndrome

1.7

10.7

178

1042

R35

ICD-10 Finland

Polyuria

1.6

10.6

242

1535

J01MA06

ATC

norfloxacin; oral

1.3

10.6

756

5914

N81.6

ICD-10 Finland

Rectocele

1.4

10.6

459

3322

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

11.2

10.5

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

10.5

1255

10470

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

10.5

2370

21072

N02CC06

ATC

eletriptan; oral

1.6

10.5

255

1643

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

10.4

375

2623

R01AD59

ATC

mometasone, combinations; nasal

1.4

10.4

423

3026

H02AB02

ATC

dexamethasone; systemic

1.4

10.4

591

4471

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

10.4

4506

42450

61001

ICD-8 Finland

Chronic cystic disease of breast, Cysta (cystis) mammae

+∞

10.4

JN3AE, ,

SPAT

1.6

10.4

237

1504

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.4

338

2320

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

10.4

200

1218

U71

ICPC

Cystitis/urinary infection other

1.4

10.3

488

3585

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

10.3

699

5428

9721

FHL

Mamilla reconstruction or transposition

12.0

10.3

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

10.3

285

1890

XKC03

NOMESCO Finland

Water cystometry

1.8

10.3

155

882

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.2

728

5692

A06AC51

ATC

ispaghula, combinations; oral

1.6

10.2

261

1700

A06AD11

ATC

lactulose; oral

1.4

10.2

591

4484

C08DA01

ATC

verapamil; systemic

1.7

10.2

187

1124

N04BC06

ATC

cabergoline; oral

3.1

10.2

138

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

10.2

2751

24836

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

3.1

10.1

133

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

10.1

1066

8763

K64.0

ICD-10 Finland

First degree haemorrhoids

1.8

10.1

136

747

C10AA07

ATC

rosuvastatin; oral

1.2

10.1

1670

14405

TAB00

NOMESCO Finland

Lumbar puncture

1.6

10.1

236

1507

ULC02

NOMESCO Finland

Hysteroscopy

1.5

10.1

359

2508

D07AC13

ATC

mometasone; topical

1.2

10.1

1563

13399

C05AA08

ATC

fluocortolone; rectal, topical

1.3

10.0

673

5223

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

2.6

9.9

218

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

9.9

290

1947

J20

ICD-10 Finland

Acute bronchitis

1.3

9.9

598

4568

G03DC02

ATC

norethisterone; oral

1.3

9.9

747

5890

N30

ICD-10 Finland

Cystitis

1.3

9.9

595

4543

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.1

9.8

400

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

9.8

377

2671

G43

ICD-10 Finland

Migraine

1.4

9.8

397

2840

R06AE09

ATC

levocetirizine; oral

1.3

9.8

858

6896

B01AB05

ATC

enoxaparin; parenteral

1.2

9.8

1632

14084

-1, ,

NOMESCO Finland

1.2

9.7

1884

16487

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.7

486

3605

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

9.7

272

1810

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

9.7

446

3263

UJH02

NOMESCO Finland

Anoscopy

1.6

9.7

208

1302

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

9.7

685

5354

R06AX13

ATC

loratadine; oral

1.3

9.6

915

7425

J45

ICD-10 Finland

Asthma

1.3

9.6

618

4762

ULA02

NOMESCO Finland

Kolposcopy

1.3

9.6

730

5759

21799

ICD-8 Finland

Benign neoplasm of breast

2.7

9.6

187

A07AA02

ATC

nystatin; oral

1.5

9.6

291

1970

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

9.6

272

1816

A29

ICPC

General symptom/complaint other

1.3

9.6

683

5343

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

9.5

263

1744

N06AX26

ATC

vortioxetine; oral

1.4

9.5

442

3238

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.6

9.5

193

1191

D07XC01

ATC

betamethasone; topical

1.4

9.5

530

3999

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

2.0

9.5

101

514

S01AA01

ATC

chloramphenicol; ophthalmic

1.5

9.5

260

1723

C09CA06

ATC

candesartan; oral

1.2

9.4

1309

11082

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.5

9.4

285

1927

N06AX12

ATC

bupropion; oral

1.4

9.4

420

3056

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

9.4

123

670

9705

FHL

Subcutaneous mastectomy

100.2

9.4

N06AA09

ATC

amitriptyline; systemic

1.4

9.4

493

3684

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

9.4

641

4983

H57.1

ICD-10 Finland

Ocular pain

1.6

9.4

238

1550

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

9.4

261

1735

1410

FHL

Laparoscopy

1.7

9.3

179

1089

A08

ICPC

Swelling

1.5

9.3

280

1891

F45.0

ICD-10 Finland

Somatization disorder

3.2

9.3

114

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

4.7

9.3

D01AE16

ATC

amorolfine; topical

1.3

9.2

536

4072

9862

FHL

Facial skin shaping surgery (Faclift)

7.3

9.2

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

9.2

103

534

H02

ICPC

Hearing complaint

1.3

9.1

647

5054

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

9.1

208

1322

D11

ICPC

Diarrhoea

1.3

9.1

730

5799

A98

ICPC

Health maint/preventive medicine

1.7

9.1

6236

61405

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

3.1

9.1

121

F13

ICPC

Eye sensation abnormal

1.7

9.1

155

915

N93.0

ICD-10 Finland

Postcoital and contact bleeding

2.3

9.1

296

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

9.0

513

3881

I49

ICD-10 Finland

Other cardiac arrhythmias

2.0

9.0

509

D10AF01

ATC

clindamycin; topical

1.5

9.0

279

1896

G43.3

ICD-10 Finland

Complicated migraine

1.8

9.0

130

731

D06BB03

ATC

aciclovir; topical

1.5

9.0

268

1808

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

9.0

194

1218

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

8.9

144

836

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.9

2445

22016

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

8.9

339

2398

N06AA12

ATC

doxepin; systemic

1.5

8.9

238

1569

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

8.9

166

1004

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

8.9

422

3105

A01AB04

ATC

amphotericin B; local oral

1.6

8.8

219

1419

ZSZ00

NOMESCO Finland

Primary repair operation

7.9

8.8

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

8.8

448

3332

A05

ICPC

Feeling ill

1.4

8.8

342

2429

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

8.8

463

3463

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

8.8

171

1045

D03

ICPC

Heartburn

1.6

8.8

219

1421

L29

ICD-10 Finland

Pruritus

2.0

8.8

466

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

8.8

195

1232

UJD02

NOMESCO Finland

Gastroscopy

1.6

8.7

209

1345

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

8.7

212

1369

G47.3

ICD-10 Finland

Sleep apnoea

1.2

8.6

952

7858

EMB10

NOMESCO Finland

Tonsillectomy

1.4

8.6

330

2339

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

8.6

282

1940

M01AH02

ATC

rofecoxib; oral

1.3

8.6

581

4510

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.0

8.6

125

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

8.6

596

4643

N03AE01

ATC

clonazepam; systemic

1.5

8.6

272

1860

X79

ICPC

Benign neoplasm breast female

10.0

8.5

H01

ICPC

Ear pain/earache

1.3

8.5

719

5749

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

8.5

334

2378

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.0

8.5

451

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

2.7

8.5

159

L91.0

ICD-10 Finland

Hypertrophic scar

2.1

8.5

384

L14

ICPC

Leg/thigh symptom/complaint

1.4

8.4

427

3174

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.3

8.4

559

4328

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.7

8.4

138

807

A02BA04

ATC

nizatidine; systemic

1.4

8.4

319

2259

G50.1

ICD-10 Finland

Atypical facial pain

1.8

8.4

112

616

R03BA08

ATC

ciclesonide; inhalant

1.3

8.4

495

3770

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.3

8.4

803

6522

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.6

8.3

179

1122

6113A

ICD-9 Finland

Other disorders of breast, Fat necrosis of breast

+∞

8.3

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

4.0

8.3

R19.5

ICD-10 Finland

Other faecal abnormalities

1.9

8.3

105

567

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

8.3

330

2355

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

8.3

151

909

O99.80

ICD-10 Finland

The fear of childbirth

1.4

8.2

318

2257

KMAK, ,

NOMESCO Finland

1.2

8.2

3051

28089

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

8.2

308

2176

N02CC04

ATC

rizatriptan; oral

1.4

8.2

381

2794

K58.1

ICD-10 Finland

Irritable bowel syndrome with predominant diarrhoea [IBS-D]

2.3

8.2

240

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

8.2

878

7224

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

8.1

173

1082

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

8.1

278

1930

O91.1

ICD-10 Finland

Abscess of breast associated with childbirth

4.5

8.1

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.4

8.1

299

2106

P06

ICPC

Sleep disturbance

1.3

8.1

737

5947

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

8.1

148

892

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

8.0

190

1219

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

8.0

182

1156

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

8.0

163

1008

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.7

8.0

144

863

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.7

8.0

147

886

D07AB08

ATC

desonide; topical

1.3

8.0

557

4341

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.0

8.0

413

D10BA01

ATC

isotretinoin; oral

1.4

8.0

351

2550

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

8.0

529

4095

G01AF04

ATC

miconazole; vaginal

1.4

8.0

327

2348

M54.8

ICD-10 Finland

Other dorsalgia

1.5

7.9

260

1791

M54

ICD-10 Finland

Dorsalgia

1.3

7.8

711

5734

R11

ICD-10 Finland

Nausea and vomiting

1.3

7.8

486

3729

O91.2

ICD-10 Finland

Nonpurulent mastitis associated with childbirth

2.0

7.8

369

M77.4

ICD-10 Finland

Metatarsalgia

1.4

7.8

367

2697

R02

ICPC

Shortness of breath/dyspnoea

1.3

7.8

691

5557

D07AA02

ATC

hydrocortisone; topical

1.3

7.8

738

5984

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

7.8

372

2742

A60

ICPC

General and Unspecified, Result test/procedure

1.5

7.8

212

1406

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.8

7.8

111

624

9719

FHL

Other measure in this category

6.9

7.8

D06BX01

ATC

metronidazole; topical

1.3

7.8

648

5173

S83.2

ICD-10 Finland

Tear of meniscus, current

1.4

7.7

286

2016

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.0

7.7

405

D07CB01

ATC

triamcinolone and antibiotics; topical

1.9

7.7

496

HA1S1

NOMESCO Finland

Photography of breasts

3.5

7.7

SAA04

NOMESCO Finland

Special examination of mouth

1.5

7.7

253

1744

L57.4

ICD-10 Finland

Cutis laxa senilis

4.3

7.7

R75

ICPC

Sinusitis acute/chronic

1.4

7.7

313

2246

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.9

7.6

504

D16

ICPC

Rectal bleeding

1.7

7.6

119

686

G04BD09

ATC

trospium; oral

1.7

7.6

119

686

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.6

146

890

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.7

7.6

120

694

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

7.6

350

2563

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

7.6

3141

29081

S10

ICPC

Boil/carbuncle

1.4

7.6

274

1923

HA1DG, ,

SPAT

11.8

7.6

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

2.5

7.6

175

NA2AA, ,

SPAT

2.2

7.5

281

G03DA02

ATC

medroxyprogesterone; systemic

1.3

7.5

587

4646

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.6

7.5

174

1113

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

7.5

211

1409

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

1.7

7.4

118

684

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

7.4

1039

8786

1413

FHL

Laparoscopy and other therapeutic procedure

1.6

7.4

151

936

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.1

7.4

316

N03AX09

ATC

lamotrigine; oral

1.4

7.4

269

1891

S20.2

ICD-10 Finland

Contusion of thorax

1.5

7.4

219

1479

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.4

1432

12485

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

7.4

134

807

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.6

7.3

144

884

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.5

7.3

187

1222

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

7.3

212

1425

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

7.3

230

1572

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

7.3

194

1280

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.3

7.3

504

3925

N03AX11

ATC

topiramate; oral

1.6

7.3

154

964

5702

FHL

Local lymph node removal (eg armpit, groin)

3.5

7.3

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

7.2

266

1873

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

3.3

7.2

21899

ICD-8 Finland

Uterine fibroma

1.5

7.2

191

1260

N94.1

ICD-10 Finland

Dyspareunia

1.8

7.2

551

N02CD01

ATC

erenumab; parenteral

2.1

7.2

300

ZXE40

NOMESCO Finland

More than seven and less than nine hours

1.9

7.2

451

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

2.4

7.2

198

N89

ICPC

Migraine

1.4

7.2

253

1769

F32

ICD-10 Finland

Depressive episode

1.4

7.1

313

2274

S02

ICPC

Pruritus

1.5

7.1

187

1230

N02BF01

ATC

gabapentin; oral

1.3

7.1

566

4489

R23

ICD-10 Finland

Other skin changes

2.0

7.1

341

ELB10

NOMESCO Finland

Excision of minor salivary gland

3.5

7.1

N06AA06

ATC

trimipramine; systemic

1.7

7.1

114

663

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.3

7.1

211

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

2.3

7.1

230

SPAT1153

SPAT

Removal of sutures

1.2

7.1

1488

13053

L16

ICPC

Ankle symptom/complaint

1.3

7.1

681

5530

XQ802

NOMESCO Finland

Epicutan test

1.5

7.1

246

1715

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.8

7.0

511

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

7.0

195

1299

R04

ICPC

Breathing problem other

1.5

7.0

182

1195

R01AD05

ATC

budesonide; nasal

1.3

7.0

389

2936

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

2.4

7.0

194

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

7.0

174

1132

K24

ICPC

Fear of heart disease

1.7

7.0

120

712

L20.0

ICD-10 Finland

Besnier prurigo

1.3

7.0

436

3349

R51.81

ICD-10 Finland

Facial pain NOS

1.6

7.0

142

881

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.0

7.0

324

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

7.0

1282

11119

A07DA03

ATC

loperamide; oral

1.6

6.9

134

820

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

6.9

168

1086

N05CB02

ATC

barbiturates in combination with other drugs

1.7

6.9

119

707

G03AC03

ATC

levonorgestrel; oral, implant

1.2

6.9

777

6424

H53.2

ICD-10 Finland

Diplopia

1.6

6.9

139

861

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

6.8

1456

12782

R01BA01

ATC

phenylpropanolamine; oral

1.4

6.8

277

1987

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

6.8

161

1035

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.8

1502

13224

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.8

6.8

502

N76.6

ICD-10 Finland

Ulceration of vulva

2.0

6.8

320

H93.1

ICD-10 Finland

Tinnitus

1.4

6.8

335

2483

NK6QA, ,

SPAT

1.9

6.8

403

E0001A1, ,

ATC

1.7

6.8

112

658

H60.8

ICD-10 Finland

Other otitis externa

1.6

6.8

162

1045

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.4

6.8

322

2373

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.4

6.8

251

1772

N06AG02

ATC

moclobemide; oral

1.5

6.8

192

1286

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

6.8

211

1441

EP1AE, ,

SPAT

1.6

6.7

150

951

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.3

6.7

417

3198

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

1.7

6.7

114

674

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.7

137

850

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

6.7

301

2196

A04AA55

ATC

palonosetron, combinations; systemic

1.5

6.7

222

1533

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

6.7

310

2273

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

3.5

6.7

L20

ICPC

Joint symptom/complaint NOS

1.5

6.7

223

1543

NG2AA

NOMESCO Finland

Patella X-ray examination

1.6

6.7

139

868

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.5

6.7

226

1569

R03BC03

ATC

nedocromil; inhalant

1.4

6.7

351

2629

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1.5

6.7

196

1323

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.5

6.6

208

1422

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

6.6

115

685

AA1CG, ,

SPAT

2.0

6.6

310

D10AX03

ATC

azelaic acid; topical

1.3

6.6

463

3613

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

6.6

281

2033

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.0

6.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

6.6

601

4849

L60.0

ICD-10 Finland

Ingrowing nail

1.4

6.6

236

1656

XF404

NOMESCO Finland

Ambulatory ECG

1.4

6.6

335

2496

UJD02, ,

SPAT

2.4

6.6

169

N06AA10

ATC

nortriptyline; systemic

1.7

6.6

112

664

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.7

6.6

117

702

NA1BA, ,

SPAT

2.2

6.5

232

DM1QA, ,

SPAT

1.4

6.5

260

1859

C03DA01

ATC

spironolactone; oral

1.3

6.5

470

3681

H81

ICPC

Excessive ear wax

1.2

6.5

691

5672

N06BA04

ATC

methylphenidate; oral

1.5

6.5

182

1215

G04BD07

ATC

tolterodine; oral

1.5

6.5

202

1378

H01.0

ICD-10 Finland

Blepharitis

1.3

6.5

397

3039

M77.1

ICD-10 Finland

Lateral epicondylitis

1.3

6.5

447

3480

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

2.0

6.5

347

G03DC05

ATC

[U] tibolone

1.4

6.5

250

1779

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.6

6.4

142

899

N04BC05

ATC

pramipexole; oral

1.3

6.4

352

2652

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

6.4

318

2359

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

6.4

367

2783

H29

ICPC

Ear symptom/complaint other

1.3

6.4

610

4946

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

2.9

6.4

L63.8

ICD-10 Finland

Other alopecia areata

2.9

6.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.4

454

3549

D93

ICPC

Irritable bowel syndrome

1.8

6.4

469

M01AX05

ATC

glucosamine; oral

1.2

6.4

882

7446

F43.0

ICD-10 Finland

Acute stress reaction

1.3

6.4

378

2884

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

6.4

530

4231

QAJ30

NOMESCO Finland

Other facelift

3.7

6.4

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

6.3

1194

10368

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

6.3

218

1519

R52.0

ICD-10 Finland

Acute pain

1.5

6.3

177

1184

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.3

6.3

453

3549

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.0

6.3

337

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

1.8

6.3

436

61008

ICD-8 Finland

Chronic cystic disease of breast, Alia definita

+∞

6.2

61009, ,

ICD-8 Finland

+∞

6.2

K03.00

ICD-10 Finland

Approximal wear

1.3

6.2

399

3076

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.2

423

3288

D07

ICPC

Dyspepsia/indigestion

2.7

6.2

120

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

6.2

225

1582

JAH01

NOMESCO Finland

Laparoscopy

1.4

6.2

262

1893

N80

ICD-10 Finland

Endometriosis

2.0

6.2

297

H02.3

ICD-10 Finland

Blepharochalasis

1.4

6.2

323

2415

M35.7

ICD-10 Finland

Hypermobility syndrome

1.7

6.2

100

584

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.5

6.2

159

1043

JN4BD

NOMESCO Finland

Extensive body CT

1.3

6.2

385

2956

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

6.2

2189

19949

P01AB02

ATC

tinidazole; oral, rectal

1.5

6.2

165

1092

O92.0

ICD-10 Finland

Retracted nipple associated with childbirth

5.0

6.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

6.2

267

1939

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.7

6.2

116

707

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.9

6.2

417

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.7

6.1

100

586

A06AX04

ATC

linaclotide; oral

2.9

6.1

-60

ICPC

Result test/procedure

1.4

6.1

268

1949

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.6

6.1

137

871

R09.1

ICD-10 Finland

Pleurisy

1.8

6.1

490

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.5

6.1

188

1281

L50.9

ICD-10 Finland

Urticaria, unspecified

1.4

6.1

222

1562

M54.3

ICD-10 Finland

Sciatica

1.4

6.1

301

2232

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.8

6.1

520

A85

ICPC

Adverse effect medical agent

2.0

6.1

313

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.4

6.1

214

1497

N92.3

ICD-10 Finland

Ovulation bleeding

2.8

6.1

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.1

604

4923

T81.9

ICD-10 Finland

Unspecified complication of procedure

1.8

6.1

477

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.8

6.1

499

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.4

6.1

278

2038

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.7

6.1

536

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

6.1

473

3745

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.0

517

4141

H71

ICPC

Acute otitis media/myringitis

1.9

6.0

370

Z50.1

ICD-10 Finland

Other physical therapy

1.4

6.0

231

1642

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.0

6.0

294

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

1.9

6.0

413

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

6.0

348

2646

A92

ICPC

Allergy/allergic reaction NOS

1.5

6.0

185

1262

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

3585

25285

1.95

144.06

2.4

2.1

—

(3044640) Blood type and Crossmatch panel - Blood

2643

18976

1.67

81.95

2.3

2.2

—

(4035726) Immunohistochemistry procedure

940

5051

2.01

76.14

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2035

14246

1.63

65.94

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3680

29613

1.57

65.38

6.1

6.0

9.80

10.06

umol/l

1.22

3502

28059

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5019

43700

1.70

62.72

8.4

7.9

73.87

76.68

u/l

6.38

4798

41462

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5022

44005

1.67

58.07

4.9

4.5

10.21

11.77

mm/h

19.23

4777

41479

(3013650) Neutrophils [#/volume] in Blood by Automated count

4025

33778

1.52

53.40

9.1

9.6

3.80

3.96

e9/l

5.26

3500

29420

(3002256) Pathology report gross observation

1212

7948

1.65

48.61

1.3

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

3408

28024

1.46

47.10

6.0

6.3

56.10

56.72

2.66

3212

26771

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3383

27843

1.46

46.11

2.7

—

estimate

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5842

54203

1.93

45.88

14.5

13.3

85.39

84.50

ml/min/173m2

2.95

5410

49759

(3019225) pH of Specimen

865

5292

1.73

44.71

4.3

3.9

7.36

0.25

593

3677

(3013115) Eosinophils [#/volume] in Blood

3713

31271

1.45

43.69

6.2

6.5

0.18

e9/l

0.98

3262

27505

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3532

29509

1.44

43.13

2.8

2.5

79.71

77.84

nmol/l

3.72

3266

27166

(3006315) Basophils [#/volume] in Blood

3612

30303

1.44

43.12

6.0

6.3

0.04

e9/l

0.33

3109

26176

(3019069) Monocytes/Leukocytes in Blood

3347

27713

1.44

42.76

6.2

6.5

8.31

8.45

2.50

3115

26011

(3002030) Lymphocytes/Leukocytes in Blood

3429

28521

1.44

42.71

6.1

6.4

29.72

28.98

4.20

3231

27036

(3001604) Monocytes [#/volume] in Blood

3599

30231

1.44

42.29

6.0

6.3

0.52

0.54

e9/l

7.97

3105

26136

(3006504) Eosinophils/Leukocytes in Blood

3338

27660

1.43

42.24

6.2

6.4

2.84

2.78

0.85

3104

25934

(3022096) Basophils/Leukocytes in Blood

3337

27659

1.43

42.11

6.2

6.5

0.71

0.70

1.03

3100

25883

(3019198) Lymphocytes [#/volume] in Blood

3663

30964

1.43

40.92

6.0

6.3

1.96

1.93

e9/l

0.44

3252

27423

(3021387) Prolactin [Units/volume] in Serum or Plasma

528

2855

1.93

40.71

1.7

331.22

311.54

mu/l

0.14

493

2541

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3045

24947

1.42

40.25

2.2

2.0

104.44

99.36

pmol/l

6.04

1481

12579

(3015377) Calcium [Moles/volume] in Serum or Plasma

2607

20799

1.43

39.83

3.6

3.4

2.37

2.36

mmol/l

1.26

2352

19004

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5921

55529

1.93

39.81

7.1

6.1

1.74

1.83

mu/l

6.89

5606

52361

(40768797) Stomach Pathology biopsy report

1223

8397

1.56

39.55

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6023

56860

2.07

39.07

16.0

14.0

18.61

20.60

mg/l

5.67

4977

46200

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1828

13687

1.47

39.04

1.8

1.7

0.97

1.02

mg/l

0.16

1370

10484

(3048689) Calprotectin [Mass/mass] in Stool

1303

9168

1.53

37.47

2.2

2.3

81.65

114.72

ug/g

6.30

1031

7197

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

305

1387

2.26

37.34

3.9

3.8

26.09

33.75

u/ml

0.94

296

1340

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

333

1582

2.17

36.60

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4573

40666

1.44

35.81

5.2

4.7

2.51

2.21

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5387

49561

1.56

35.01

5.7

5.1

14.53

14.60

pmol/l

1.50

5070

46323

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

999

6737

1.57

34.47

4.9

4.6

33.34

33.33

0.01

666

4571

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2264

18098

1.39

32.11

2.6

57.29

58.66

u/l

0.50

2107

16697

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3324

28294

1.37

31.70

6.4

1.22

mmol/l

1.23

2988

24344

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

215

909

2.41

31.14

1.9

1.7

407.38

385.99

mu/l

0.17

172

729

(3031040) Bacteria [#/volume] in Urine by Automated count

4438

39645

1.39

30.84

5.3

4.7

3250.16

2219.62

e6/l

0.39

463

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3708

32220

1.36

30.37

3.4

3.2

82.73

85.62

ug/l

0.40

3526

30360

(3019550) Sodium [Moles/volume] in Serum or Plasma

5974

56776

1.83

29.96

16.8

15.4

139.71

139.67

mmol/l

0.62

5888

55656

(3033658) Prothrombin time (PT) actual/Normal

1816

14129

1.40

29.72

3.8

3.7

96.92

95.53

1.69

1779

13738

(40768443) Skin Pathology biopsy report

480

2788

1.78

29.22

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5976

56892

1.81

28.50

17.0

15.5

3.92

mmol/l

0.20

5883

55647

(3007164) IgA [Mass/volume] in Serum or Plasma

1779

13875

1.39

28.45

1.5

2.11

2.21

g/l

1.36

1048

8646

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2059

16510

1.37

27.55

1.4

1.3

1.17

1.54

u/ml

0.99

526

4683

(3024561) Albumin [Mass/volume] in Serum or Plasma

2967

25155

1.34

27.36

4.2

4.6

37.08

36.23

g/l

16.62

2802

23569

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2967

25208

1.33

26.72

5.7

5.8

1.22

mmol/l

1.54

2767

23331

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4428

39985

1.35

25.66

3.5

3.1

36.40

38.40

u/l

0.86

4180

37805

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2059

16662

1.35

25.47

2.1

137.40

158.22

u/l

0.91

1957

15730

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1603

12495

1.38

25.14

1.4

1.3

10.10

10.59

u/ml

0.08

584

5104

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1713

13529

1.36

24.65

1.4

27.97

28.61

iu/ml

0.07

497

4210

(42870588) Differential panel, method unspecified - Blood

2375

19698

1.33

24.63

6.2

6.3

—

4.37

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6171

59607

2.10

24.55

13.0

11.6

23.56

23.59

u/l

0.03

6070

58053

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

700

4687

1.55

24.37

2.5

2.4

19.97

23.04

au/ml

0.49

559

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6179

59735

2.12

24.16

19.6

17.5

67.84

68.39

umol/l

1.09

6124

59063

(3013826) Glucose [Moles/volume] in Serum or Plasma

3650

32189

1.31

24.09

4.4

6.31

6.45

mmol/l

4.41

3434

29985

(3036481) Cortisol [Moles/volume] in Serum or Plasma

874

6167

1.48

23.71

2.1

2.2

379.44

381.86

nmol/l

0.14

810

5707

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

653

4359

1.55

22.98

1.3

55.12

46.92

au/ml

0.35

276

(36660697) Celiac disease serology panel - Serum

820

5774

1.48

22.39

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

697

4768

1.52

21.88

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

103

368

2.83

21.09

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2310

19438

1.30

20.43

3.4

3.3

28.98

64.70

ng/l

0.68

1279

11522

(3021960) Folate [Moles/volume] in Serum or Plasma

1926

15836

1.31

20.21

1.7

1.6

22.11

21.10

nmol/l

2.27

1630

13493

(3022145) Colonoscopy Study observation

926

6800

1.42

20.10

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

2157

18023

1.30

20.02

3.0

0.00

0.05

2.71

362

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1467

11679

1.33

19.18

2.5

2.8

2.44

2.45

mmol/l

2.37

1312

10487

(3015736) pH of Urine

2945

25741

1.27

18.63

3.6

3.5

6.27

6.26

0.31

1656

14353

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5523

52369

1.41

18.59

6.0

5.7

37.71

38.14

mmol/mol

4.34

5245

49369

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5556

52788

1.41

18.01

4.3

4.0

1.21

1.22

mmol/l

0.52

5225

49083

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

394

2481

1.63

17.68

1.4

1.7

3.32

4.11

mg/l

1.27

283

1827

(3037522) Nuclear Ab [Titer] in Serum

1247

9810

1.34

17.47

1.5

1.4

459.28

582.64

titre

1.99

305

2237

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

635

4464

1.47

17.28

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

776

5672

1.42

17.12

2.4

2.3

35.07

37.76

u/l

0.37

669

4724

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5677

54257

1.42

16.71

5.2

4.8

5.70

5.74

mmol/l

1.97

5326

50491

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1698

14027

1.29

16.50

2.7

2.9

840.49

986.97

ng/l

0.78

1417

11891

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4387

40489

1.27

16.34

3.8

3.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

137

639

2.17

15.92

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

525

3650

1.48

15.07

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5817

56013

1.44

14.75

5.2

4.8

4.82

4.83

mmol/l

0.37

5536

52855

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

362

2336

1.58

14.69

1.3

40.31

42.18

u/ml

0.04

148

(3042936) Bacteria identified in Isolate by Culture

957

7426

1.34

14.46

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

735

5508

1.38

13.87

3.6

4.0

10.69

25.54

ug/l

1.14

546

4302

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1061

8408

1.31

13.78

2.4

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5863

56630

1.44

13.69

5.8

5.4

2.81

2.83

mmol/l

0.71

5567

53226

(3000494) Fungus identified in Specimen by Culture

916

7116

1.34

13.68

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

296

1855

1.62

13.58

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

201

2.95

13.31

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5781

55742

1.40

13.22

5.1

4.7

1.59

1.58

mmol/l

1.92

5479

52332

(3007853) Bacteria identified in Skin by Aerobe culture

842

6513

1.34

12.90

1.8

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

687

5165

1.37

12.66

2.1

2.2

0.23

0.21

g/l

8.18

646

4861

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

840

6516

1.33

12.61

2.2

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

3571

32654

1.21

12.51

4.1

4.0

1.82

0.32

estimate

0.39

553

6645

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

531

3835

1.42

12.42

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

329

2161

1.55

12.38

1.3

5.97

3.96

u/ml

0.23

204

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1146

9295

1.28

12.36

2.5

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

622

4626

1.38

12.25

1.4

1.3

176.29

182.50

u/ml

0.07

582

4304

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1799

15395

1.23

12.18

2.3

2.63

2.73

mg/l

1.16

1544

13352

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

405

2791

1.48

12.15

2.1

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

285

1822

1.59

12.07

1.4

293.84

285.50

ug/g

0.29

156

978

(3035941) MCH [Entitic mass]

6283

61823

2.13

12.07

25.0

21.7

30.20

30.12

4.13

6254

61318

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6283

61826

2.13

12.02

25.0

21.7

90.98

90.79

2.99

6254

61319

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6283

61827

2.12

12.00

25.4

22.1

39.84

40.26

1.35

6253

61292

(3026361) Erythrocytes [#/volume] in Blood

6283

61829

2.12

11.97

25.1

21.8

4.42

e12/l

0.01

6202

60611

(3021601) Nitrite [Presence] in Urine by Test strip

3504

32057

1.21

11.94

4.1

4.0

0.00

estimate

0.34

565

6658

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

267

1686

1.61

11.91

1.2

—

(3007461) Platelets [#/volume] in Blood

6281

61811

2.10

11.81

25.2

21.8

263.45

266.52

e9/l

3.75

6210

60764

(3000963) Hemoglobin [Mass/volume] in Blood

6283

61841

2.11

11.76

25.3

21.9

132.66

132.23

g/l

2.60

6257

61343

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

412

2868

1.47

11.75

2.4

2.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1737

14866

1.23

11.65

3.8

3.9

0.71

0.54

—

133

(3010813) Leukocytes [#/volume] in Blood

6282

61835

2.09

11.63

25.2

21.8

6.51

6.61

e9/l

3.58

6201

60599

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

492

3549

1.42

11.58

1.1

1.98

2.17

u/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

3530

32390

1.20

11.40

4.1

4.0

6.47

4.54

estimate

0.21

579

6852

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

697

5346

1.34

11.25

2.0

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

850

6713

1.31

11.16

2.4

5.34

7.10

umol/l

3.89

711

5704

(3014765) Yersinia sp identified in Stool by Organism specific culture

265

1698

1.58

11.14

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

266

1706

1.58

11.14

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

322

2164

1.51

10.93

1.3

1.4

3.53

8.47

u/ml

2.78

341

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

388

2712

1.46

10.84

1.7

1.6

9.69

13.55

u/ml

1.39

640

(3023323) Follitropin [Units/volume] in Serum or Plasma

679

5216

1.34

10.83

1.4

1.3

27.48

28.40

iu/l

0.29

601

4517

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1045

8523

1.27

10.64

2.7

2.8

5.95

4.63

e6/l

0.52

475

3833

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

277

1819

1.55

10.48

1.3

40.61

44.49

u/ml

0.11

193

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

995

8081

1.27

10.47

1.6

1.5

—

(3022621) pH of Urine by Test strip

658

5061

1.33

10.40

2.8

2.6

6.14

0.03

398

3273

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2238

19809

1.20

10.38

3.2

3.1

28.81

30.88

u/l

1.44

2122

18713

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

278

1834

1.54

10.30

2.1

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

669

5165

1.33

10.30

2.7

3.6

35.63

55.84

u/ml

3.36

649

4993

(3034274) Bile acid [Moles/volume] in Serum --fasting

206

1267

1.65

10.26

2.0

2.3

5.20

6.11

umol/l

0.47

156

926

(3026493) Urate [Moles/volume] in Serum or Plasma

1629

14022

1.22

10.06

2.2

2.3

300.53

309.23

umol/l

3.25

1428

12451

(3018095) Leukocytes [#/volume] in Urine

2387

21295

1.19

10.06

3.9

3.7

65.43

96.46

e6/l

2.88

1588

14124

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

707

5520

1.32

10.05

1.6

3.48

3.46

mmol/l

0.23

474

3690

(1002224) Polysomnography panel

393

2796

1.43

10.00

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

295

1993

1.50

9.80

2.2

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

213

1340

1.61

9.71

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

312

2140

1.48

9.62

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

140

790

1.79

9.56

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

228

1464

1.58

9.55

1.5

1.4

26.68

28.92

u/l

0.47

194

1204

(3045424) Erythrocytes [Presence] in Urine

405

2922

1.41

9.54

2.0

2.1

0.03

0.02

estimate

0.21

115

998

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

896

7270

1.27

9.45

1.9

1.8

3.22

3.24

ratio

0.27

667

5375

(3024522) Salmonella sp identified in Specimen by Organism specific culture

139

789

1.78

9.31

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

421

3072

1.40

9.29

1.7

2.0

6.09

7.13

iu/ml

0.45

728

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1138

9514

1.24

9.22

2.6

2.7

1.21

1.69

e6/l

0.72

570

4842

(40761536) Microorganisms panel - Urine sediment

364

5025

0.71

9.21

4.0

3.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

260

1734

1.52

9.20

1.3

13.89

13.55

u/l

0.12

219

1409

(3052851) Hemolysis interference index of Serum or Plasma

230

1496

1.56

9.12

2.5

2.9

2.05

2.03

index

0.01

109

756

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

140

805

1.76

8.99

1.4

—

(3025941) Bacteria identified in Stool by Culture

469

3515

1.36

8.79

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1412

12127

1.21

8.74

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

132

754

1.77

8.69

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

290

2004

1.47

8.65

1.5

1.3

—

(3025130) Human papilloma virus identified in Specimen

245

1636

1.52

8.64

1.8

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1164

9824

1.23

8.57

3.7

3.5

140.33

293.30

ng/l

2.58

737

6687

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

132

758

1.76

8.54

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

132

760

1.75

8.46

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

123

698

1.78

8.30

1.3

1.2

41.50

45.61

u/ml

—

(3045414) Leukocytes [Presence] in Urine

738

5942

1.27

8.25

2.0

2.1

0.03

estimate

0.06

137

1214

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1061

8906

1.23

8.20

2.7

3.2

0.82

mmol/l

1.01

981

8387

(3017732) Neutrophils [#/volume] in Blood

954

7919

1.24

8.19

3.0

3.92

4.24

e9/l

2.55

781

6945

(3004616) Nuclear Ab [Presence] in Serum

149

896

1.68

8.18

1.4

1.3

—

(40758358) Immune stain study

7.52

8.14

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

334

4580

0.71

8.11

3.0

3.4

1.23

1.24

mmol/l

1.11

305

3929

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

158

968

1.65

8.08

1.3

0.26

0.25

nmol/l

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

634

5027

1.29

8.00

3.7

3.5

4.47

4.50

pmol/l

0.38

563

4536

(3002582) Erythrocytes [#/volume] in Urine

1980

17646

1.18

7.96

3.1

61.69

57.59

e6/l

0.08

1468

13107

(3015171) Extractable nuclear Ab [Units/volume] in Serum

399

2964

1.37

7.93

1.3

0.81

1.37

u/ml

0.41

239

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

598

4714

1.30

7.89

3.5

3.3

72.57

79.71

ng/l

1.83

526

4050

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

499

1.90

7.87

1.1

16.39

15.73

u/ml

0.10

234

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.58

7.83

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

199

1302

1.55

7.75

1.1

1.22

0.92

u/ml

0.24

549

(3003888) Timothy IgE Ab [Units/volume] in Serum

206

1363

1.53

7.63

1.1

4.10

4.54

u/ml

0.18

121

712

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

203

1339

1.53

7.62

1.6

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1029

8671

1.22

7.62

1.7

1102.51

1188.85

nmol/l

2.01

788

6614

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

727

5898

1.26

7.62

1.3

1.2

143.65

148.63

u/ml

0.13

300

2367

(3019420) Tryptase [Mass/volume] in Serum or Plasma

414

1.97

7.59

1.9

1.5

9.62

7.55

ug/l

0.21

375

(3018677) aPTT in Platelet poor plasma by Coagulation assay

904

7527

1.23

7.51

1.9

2.0

29.11

29.13

0.03

892

7300

(3047007) Chlamydophila sp Ab [Presence] in Serum

162

1022

1.60

7.40

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

747

6103

1.25

7.36

5.6

5.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.39

7.23

1.1

—

(40758558) Short blood count panel - Blood

1997

17918

1.17

7.22

6.6

6.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

471

1.88

7.22

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

230

1578

1.47

7.17

1.2

1.1

2.32

1.99

u/ml

0.21

129

819

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

476

1.86

7.00

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

292

2106

1.41

6.97

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

449

1.88

6.94

2.0

2.1

19.83

18.76

nmol/l

0.46

429

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

150

950

1.59

6.78

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

150

950

1.59

6.78

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1567

13851

1.17

6.77

2.1

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

104

601

1.74

6.67

1.3

1.2

51.40

59.61

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

343

1.99

6.67

1.7

2.1

100.85

102.43

0.15

310

(3032080) INR in Blood by Coagulation assay

2506

23006

1.15

6.43

10.8

11.0

1.15

1.16

inr

0.58

2035

18875

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

971

1.57

6.42

1.1

2.03

2.83

0.52

169

(3020717) Zinc [Moles/volume] in Serum or Plasma

435

1.85

6.30

1.3

1.5

28.90

23.27

umol/l

0.78

397

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

250

1792

1.41

6.22

1.3

1.93

2.82

u/ml

0.34

119

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

193

2.29

6.17

1.7

1.6

0.35

0.41

ug/l

0.58

140

(3008898) HLA-B27 [Presence]

350

2659

1.33

6.07

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

131

827

1.60

6.05

1.3

0.17

0.19

nmol/l

0.50

111

621

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

184

1252

1.48

6.04

1.1

15.13

15.70

au/ml

0.04

313

(3049717) Cytology report of Urine Cyto stain

174

1174

1.50

5.96

2.2

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

903

7693

1.20

5.90

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

1706

15314

1.16

5.90

3.0

0.31

0.37

e6/l

0.69

1194

10920

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

775

6513

1.22

5.84

1.6

1.38

1.36

0.40

687

5770

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

242

1747

1.40

5.80

2.1

2.3

162.31

184.24

4.42

229

1659

(3024891) Influenza virus A+B Ag [Presence] in Specimen

224

1601

1.41

5.70

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

186

1285

1.46

5.68

1.1

1.14

1.36

u/ml

0.17

103

622

(3020961) Endomysium IgA Ab [Titer] in Serum

441

3492

1.28

5.66

1.1

90.00

196.83

titre

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5028

48598

1.16

5.63

20.5

18.0

331.37

330.96

g/l

3.01

5012

48350

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

340

2606

1.32

5.57

2.2

2.1

42.09

40.03

u/l

1.29

319

2372

(3022313) Gas panel - Capillary blood

268

1982

1.37

5.57

3.3

3.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

435

3447

1.28

5.56

2.1

2.2

4.79

6.09

ug/l

0.78

366

2965

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

248

1812

1.38

5.55

1.2

4.45

4.38

0.03

272

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

500

4037

1.26

5.48

2.5

2.2

4776.81

5773.39

u/l

0.32

184

1653

(3036489) Thrombin time

292

2200

1.34

5.39

1.9

2.0

20.54

20.60

0.07

258

1888

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.10

5.33

1.0

1.1

0.02

0.03

u/ml

0.74

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

217

1570

1.40

5.18

3.4

24.92

24.96

mmol/l

0.08

199

1437

(3005719) IgG [Mass/volume] in Serum or Plasma

563

4657

1.23

4.97

2.7

2.9

10.20

10.36

g/l

0.50

527

4327

(3038026) Centromere Ab [Units/volume] in Serum

523

1.67

4.95

1.3

1.2

49.90

57.64

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

160

1110

1.45

4.84

1.3

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1563

14114

1.14

4.83

4.3

4.1

1.02

1.23

kg/l

0.80

1061

9300

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

420

3389

1.26

4.66

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

504

4151

1.23

4.65

1.8

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

164

1154

1.43

4.62

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

658

1.57

4.62

2.2

2.1

21.66

26.71

mg/l

0.53

247

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

950

8306

1.17

4.56

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

112

734

1.54

4.50

1.3

1.4

1.36

1.45

nmol/l

0.15

625

(3022948) Iron [Moles/volume] in Serum or Plasma

1075

9509

1.16

4.42

2.4

13.88

13.31

umol/l

1.96

1005

8827

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

214

1590

1.36

4.40

1.3

420.23

490.45

mg/l

2.65

205

1525

(3030981) Hyaline casts [#/volume] in Urine by Automated count

501

4150

1.22

4.38

2.3

0.20

0.41

e6/l

4.04

477

3925

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

483

3987

1.23

4.37

1.6

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1559

14162

1.13

4.33

3.8

4.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2645

24783

1.11

4.32

1.9

1.31

1.32

mmol/l

0.15

2290

21021

(3003694) ABO and Rh group [Type] in Blood

1951

17972

1.12

4.31

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

278

2157

1.30

4.25

1.7

1.9

1.19

g/l

0.14

271

2063

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

250

1912

1.32

4.24

1.1

1.76

7.43

eliau/ml

3.14

261

(3003458) Phosphate [Moles/volume] in Serum or Plasma

773

6686

1.18

4.24

4.8

5.0

1.04

mmol/l

0.12

700

6164

(3026008) Bacteria identified in Urine by Culture

2136

19798

1.12

4.21

3.2

3.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

147

1033

1.43

4.21

1.1

1.60

3.54

eliau/ml

3.15

506

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

402

1.70

4.18

1.4

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

403

1.69

4.14

1.6

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

421

3452

1.24

4.08

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

254

1960

1.31

4.06

4.4

2.6

—

(3023368) Bacteria identified in Blood by Culture

1445

13118

1.13

4.03

3.8

4.0

—

(3000764) Benzodiazepines [Presence] in Urine

338

2708

1.26

4.03

2.8

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

332

1.75

4.01

1.3

1.8

124.21

131.78

0.42

312

(3032057) Clostridioides difficile [Presence] in Stool

100

2.41

3.88

2.0

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

396

1.67

3.87

1.6

1.5

5.49

6.63

u/l

0.37

321

(1001926) Buprenorphine [Presence] in Urine by Screen method

269

2111

1.29

3.81

2.9

2.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

483

1.60

3.80

1.1

0.35

1.57

u/ml

0.96

152

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

434

5204

0.82

3.79

2.9

3.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

476

1.60

3.78

3.2

3.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

222

1702

1.32

3.75

2.2

2.4

3.35

3.60

g/l

2.17

208

1606

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

900

7957

1.15

3.72

2.3

2.5

22.74

22.11

0.81

829

7343

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

266

2096

1.28

3.66

1.7

2.0

0.23

g/l

0.11

260

1997

(3051611) Lipemic interference index of Serum or Plasma

520

1.56

3.64

2.6

3.0

15.15

14.09

index

0.24

284

(3027008) Opiates [Presence] in Urine

335

2719

1.24

3.60

2.8

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

361

2955

1.23

3.59

3.1

3.3

5.06

5.17

kpa

2.18

340

2830

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

283

2255

1.27

3.57

2.0

2.1

3.89

9.22

iu/l

0.75

112

990

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

102

693

1.48

3.54

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.57

3.54

2.2

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

677

1.48

3.53

1.2

55.50

60.00

u/l

0.66

596

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

220

1.87

3.53

2.4

2.3

—

(3028300) Cannabinoids [Presence] in Urine

335

2731

1.24

3.47

2.8

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

213

1644

1.31

3.45

2.5

2.2

11.27

11.51

mg/l

0.19

195

1541

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

1.85

3.44

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

119

2.19

3.43

1.0

1.1

29.81

7.06

u/ml

0.76

119

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

326

1.69

3.41

1.0

1.1

8.79

8.90

u/ml

0.01

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

388

1.63

3.39

1.1

0.11

12.91

nmol/l

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.75

3.38

1.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

143

1045

1.38

3.35

1.2

2.69

14.04

u/ml

1.66

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.62

3.32

1.1

1.2

—

(3009343) pH of Capillary blood

348

2866

1.23

3.29

3.2

3.3

7.42

1.24

283

2360

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.93

3.28

1.0

1.1

0.02

0.04

u/ml

1.16

(3010838) Calcium [Moles/time] in 24 hour Urine

167

1257

1.34

3.25

2.2

2.0

5.49

5.10

mmol/24h

0.84

148

1133

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

134

975

1.38

3.24

1.0

1.1

0.29

0.24

u/ml

0.08

287

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

560

1.51

3.23

1.2

1.1

30.81

36.13

mg/l

1.20

475

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

544

1.51

3.23

1.1

207.83

219.89

mg/l

0.38

484

(3027944) Amphetamines [Presence] in Urine

329

2700

1.23

3.22

2.7

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2566

24258

1.10

3.22

4.0

3.9

0.02

0.40

estimate

1.70

453

5452

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

632

5506

1.16

3.20

4.2

4.3

232.87

240.18

u/l

0.75

582

5217

(3033099) Centromere Ab [Titer] in Serum

179

1.90

3.13

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1730

1.28

3.13

2.3

9.47

10.06

g/l

1.44

188

1537

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

115

821

1.41

3.12

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

159

1.95

3.08

1.1

1.3

193.27

106.42

nmol/l

1.84

112

(3003129) Base excess in Capillary blood by calculation

526

1.51

3.07

2.0

2.1

0.59

0.84

mmol/l

0.27

502

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

231

1.78

3.07

1.1

102.00

94.56

0.57

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.68

3.05

2.3

2.9

—

(3016879) Cocaine [Presence] in Urine

304

2491

1.23

3.04

2.9

2.0

—

(3018418) pH of Serum or Plasma

1869

17446

1.10

3.03

3.9

7.40

0.43

1312

12334

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

577

1.48

3.02

1.1

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

229

1819

1.27

3.02

2.0

2.1

97.79

96.46

0.43

223

1736

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

378

1.59

2.99

1.5

1.4

—

(44806420) Estimation of glomerular filtration rate

866

0.63

2.95

2.2

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

969

8745

1.13

2.93

2.3

2.4

2.43

2.41

g/l

0.39

894

8020

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

115

2.09

2.87

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

115

2.09

2.87

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

115

2.09

2.87

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

236

1.74

2.87

1.1

1.0

98.53

92.48

0.60

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

240

1930

1.25

2.87

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

617

1.45

2.86

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

164

1258

1.31

2.85

1.2

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

146

1105

1.33

2.79

1.0

1.1

3.12

4.61

u/ml

0.54

484

(3018333) Ribosomal P Ab [Presence] in Serum

563

1.46

2.78

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

1.79

2.76

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

960

8696

1.12

2.73

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1885

17676

1.09

2.73

3.4

3.3

0.60

0.21

estimate

0.32

464

5450

(3003740) Influenza virus B Ag [Presence] in Specimen

163

1258

1.30

2.72

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

199

1576

1.27

2.72

1.5

0.49

0.46

nmol/l

0.07

155

1223

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

484

1.49

2.72

1.6

1.3

4.71

5.24

umol/l

0.56

439

(3028026) IgM [Mass/volume] in Serum or Plasma

425

3638

1.18

2.71

1.7

1.9

1.23

1.34

g/l

0.88

396

3361

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

517

1.48

2.71

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

152

1166

1.31

2.66

1.1

1.28

4.14

u/ml

5.60

560

(3006462) Nitrate [Presence] in Urine

288

1.64

2.65

3.6

3.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

179

1405

1.28

2.64

1.2

3.62

3.66

mmol/l

0.21

166

1337

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

322

2697

1.20

2.63

1.5

1.16

1.22

ratio

0.61

200

1637

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

322

2697

1.20

2.63

1.5

0.92

0.94

ratio

0.54

200

1625

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.21

2.63

2.2

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

321

2689

1.20

2.62

1.5

1.16

1.15

ratio

0.07

199

1616

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

1030

1.33

2.61

1.4

1.5

0.59

0.63

g/l

0.24

119

788

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

596

1.43

2.61

1.1

1.2

—

(4211845) Urine protein measurement

313

1.60

2.60

3.5

3.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

597

1.43

2.59

1.1

1.2

—

(4024509) Urine culture

351

2969

1.19

2.58

2.0

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

1307

12078

1.10

2.57

2.6

7.22

8.17

e6/l

1.39

1195

10917

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

532

1.45

2.56

1.1

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

609

1.42

2.51

1.1

1.2

—

(4062490) Immunoglobulin typing, IgG

652

1.40

2.49

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

349

1.55

2.47

1.1

1.2

16.30

19.78

u/l

0.46

314

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

158

1.84

2.47

1.1

105.28

107.40

0.20

152

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

151

1.86

2.46

3.3

3.2

1.76

1.94

ratio

0.36

140

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

1.88

2.45

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1932

1.23

2.45

2.4

2.78

2.90

g/l

1.12

206

1756

(3027231) Wheat IgE Ab [Units/volume] in Serum

137

1.90

2.45

1.0

1.1

0.50

1.31

u/ml

0.82

122

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

264

1.63

2.43

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

264

1.63

2.43

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

264

1.63

2.43

1.7

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

486

4245

1.16

2.43

6.4

6.8

1.26

1.25

mmol/l

0.03

479

4172

(3002079) Sodium [Moles/time] in 24 hour Urine

280

1.61

2.42

1.4

1.2

138.67

137.37

mmol/24h

0.05

280

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

265

1.63

2.40

1.7

1.6

—

(3023410) Appearance of Cerebral spinal fluid

632

1.40

2.39

1.3

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

352

1.54

2.39

1.1

1.2

72.69

72.86

u/l

0.01

317

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

102

752

1.36

2.37

4.2

5.0

130.39

92.29

u/ml

0.17

255

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

6.25

2.37

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

6.25

2.37

1.0

0.02

0.01

u/ml

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

294

2471

1.20

2.35

3.1

3.2

1.62

1.85

mmol/l

0.51

211

1844

(3024139) IgG subclass 3 [Mass/volume] in Serum

668

1.38

2.35

1.4

0.39

g/l

0.08

475

(3027135) IgG subclass 1 [Mass/volume] in Serum

668

1.38

2.35

1.4

6.18

6.59

g/l

0.90

476

(3028192) IgG subclass 2 [Mass/volume] in Serum

668

1.38

2.35

1.4

3.13

2.85

g/l

0.69

476

(3027945) Reticulocytes/Erythrocytes in Blood

601

5344

1.14

2.33

2.6

2.5

1.70

1.81

2.23

524

4738

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

314

2657

1.19

2.33

1.5

—

(3026782) Osmolality of Urine

1098

10111

1.10

2.31

2.7

2.8

495.69

499.19

mosm/kgh2o

0.22

961

8808

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

222

1.67

2.30

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

246

1.63

2.27

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

580

1.40

2.26

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

108

811

1.34

2.25

1.4

1.3

595.07

369.75

pmol/l

0.46

705

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

113

1.95

2.24

1.2

1.4

1.18

mmol/l

0.05

113

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

498

1.43

2.22

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

2019

1.21

2.21

2.3

3.52

3.64

g/l

0.27

213

1845

(3044290) Cell count panel - Cerebral spinal fluid

165

1315

1.26

2.21

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

172

1378

1.26

2.20

1.3

7.02

34.89

e6/l

1.92

122

997

(3012501) Base excess in Blood by calculation

971

0.71

2.19

3.0

3.2

2.65

2.57

mmol/l

0.07

646

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

417

1.47

2.19

3.1

2.4

243.02

215.78

e6/l

0.57

342

(3029937) Albumin [Presence] in Urine by Test strip

1848

17457

1.08

2.19

4.2

0.00

estimate

2.79

562

6400

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

2022

1.21

2.18

2.4

2.3

4.30

g/l

0.02

213

1845

(1616796) Gas panel - Central venous blood

1051

0.72

2.17

2.4

3.3

—

(3024869) Neuronal Ab [Presence] in Serum

2.07

2.16

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

2025

1.21

2.15

2.4

2.3

7.01

7.49

g/l

4.70

213

1848

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

242

1.62

2.15

1.0

1.1

7.78

12.48

u/ml

0.83

168

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

144

1.81

2.14

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

461

1.44

2.13

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

189

1.70

2.12

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.45

2.10

1.1

0.60

0.58

iu/ml

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

145

1.80

2.10

1.1

77.20

70.34

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

145

1.80

2.10

1.1

89.40

83.35

—

(3006567) Chloride [Moles/time] in 24 hour Urine

5.00

2.07

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

121

938

1.30

2.04

1.2

1.3

413.33

350.70

titre

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

139

1097

1.27

2.04

3.3

3.5

19.14

24.21

mg/l

1.39

755

(3028707) Methadone [Presence] in Urine by Screen method

148

1178

1.26

2.03

4.2

2.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

326

2806

1.17

2.02

1.3

1.4

202.12

237.18

miu/ml

1.15

157

1402

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

332

2862

1.17

2.02

1.5

60.49

60.98

ug/l

0.07

276

2369

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

585

1.37

2.01

1.3

1.2

122.87

115.47

pmol/l

0.66

585

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

172

1396

1.24

2.00

1.4

157.10

4442.23

e6/l

0.91

126

1084

(3037121) Protein [Mass/volume] in Urine

215

1786

1.21

1.99

2.8

3.1

265.67

416.09

mg/l

1.07

681

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1034

0.73

1.99

2.4

2.5

13.20

13.19

0.02

1020

(4146454) Self-monitoring of blood glucose

493

1.40

1.99

2.8

2.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

269

2283

1.19

1.98

1.4

1.5

91.28

149.97

pmol/l

3.26

264

2224

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

394

1.45

1.96

2.9

2.3

546.30

508.85

e6/l

0.23

306

(3008295) Osmolality of Serum or Plasma

632

1.35

1.93

1.4

1.5

277.95

276.70

mosm/kgh2o

0.21

487

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

127

1002

1.27

1.89

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

414

1.43

1.89

3.3

4.0

—

(3035933) Granulocytes/Leukocytes in Blood

108

1383

0.78

1.86

2.6

3.2

57.43

57.82

0.15

108

1383

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

251

2134

1.18

1.83

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

417

1.42

1.83

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

417

1.42

1.83

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

417

1.42

1.83

1.6

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

128

1018

1.26

1.80

1.3

1.2

3.29

3.79

u/ml

0.21

437

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

101

1.88

1.80

1.6

1.5

0.19

0.32

nmol/l

0.65

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

164

1342

1.23

1.80

2.6

2.4

0.00

g/l

-0.00

151

1263

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

211

1773

1.20

1.77

2.5

2.3

0.53

0.64

g/l

0.21

177

1526

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

146

1.72

1.77

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

437

1.40

1.76

1.1

1.0

0.58

0.29

u/ml

—

105

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

488

1.38

1.76

1.2

1.4

1.86

2.04

mmol/l

1.58

455

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

149

1210

1.24

1.76

1.2

261.45

267.54

u/ml

0.11

756

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.22

1.73

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

147

1.70

1.73

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

473

1.38

1.72

1.1

1.0

0.57

1.17

u/ml

0.64

112

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.92

1.72

1.0

1.1

0.01

u/ml

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.88

1.70

1.1

1.0

0.18

0.30

u/ml

0.15

(3022806) Fractional oxyhemoglobin in Capillary blood

553

0.67

1.69

1.4

1.7

91.63

90.16

1.21

545

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

343

3010

1.15

1.69

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

475

1.37

1.69

5.5

6.8

15.42

68.54

ug/l

0.77

299

(3021879) Hepatitis B virus core Ab [Presence] in Serum

572

5186

1.11

1.67

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1250

11748

1.08

1.66

1.6

1.7

47075427.42

30519535.37

pmol/l

0.45

1094

9902

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.58

1.65

1.0

—

(3000991) Gas panel - Venous blood

450

4028

1.13

1.64

8.0

8.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

326

1.44

1.64

1.7

1.8

1.95

1.91

umol/l

0.13

298

(3047352) Trisomy 18 risk [Likelihood] in Fetus

258

2223

1.17

1.64

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

487

1.36

1.62

2.4

2.7

22.22

24.24

mg/l

0.19

349

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

548

1.34

1.61

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

113

1.77

1.60

1.1

1.61

0.59

umol/24h

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

182

1.60

1.59

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

230

1.52

1.59

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

230

1.52

1.59

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

472

1.36

1.59

1.1

302.45

299.44

mg/l

0.13

421

(37021550) Renin [Units/volume] in Plasma --upright

106

1.79

1.58

1.2

77.66

69.70

mu/l

0.05

(40768446) Kidney Pathology biopsy report

174

0.46

1.57

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

231

1.52

1.56

1.1

58.03

57.78

u/ml

0.01

225

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.88

1.54

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

129

1050

1.23

1.53

1.2

3.59

2.89

u/ml

0.22

375

(3008152) Bicarbonate [Moles/volume] in Arterial blood

237

2743

0.86

1.53

6.0

6.6

24.95

24.66

mmol/l

0.72

231

2616

(3017354) Segmented neutrophils/Leukocytes in Blood

502

1.34

1.52

3.6

3.4

58.99

56.12

0.56

450

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

494

1.34

1.50

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

401

1.37

1.48

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

444

1.35

1.48

4.0

2.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

159

1328

1.20

1.48

1.7

7282.54

9464.89

e6/l

0.60

106

929

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

402

1.37

1.46

1.1

1.0

0.94

1.07

u/l

2.67

150

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

355

0.62

1.46

1.2

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

584

1.31

1.46

1.1

6.51

8.66

iu/ml

0.67

153

(4268621) Lupus anticoagulant assay

734

1.27

1.45

2.2

—

(3005033) Fetal Nuchal fold Thickness US

251

2184

1.16

1.44

1.5

1.23

1.25

0.33

182

1576

(3036670) Protein [Mass/volume] in Synovial fluid

148

1.62

1.43

1.2

1.3

36.25

39.29

g/l

0.59

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.97

1.43

1.2

1.1

1.66

1.86

iu/ml

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

345

1.39

1.42

1.5

1.3

26.25

65.38

titre

—

(3002032) Base excess in Venous blood by calculation

484

4394

1.11

1.41

3.9

3.5

2.22

1.87

mmol/l

1.30

441

3896

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

380

1.37

1.40

1.5

4.53

5.19

u/l

1.11

329

(3012494) Peanut IgE Ab [Units/volume] in Serum

205

1.51

1.40

1.1

0.24

2.89

u/ml

1.73

116

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

171

1447

1.19

1.39

2.6

2.3

0.00

g/l

0.39

152

1268

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.20

1.36

1.6

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

180

1534

1.18

1.36

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

273

1.43

1.34

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

383

1.36

1.34

1.2

1.4

35233.94

61709.13

e6/l

0.39

191

(3043238) Trisomy 21 risk [Likelihood] in Fetus

260

2282

1.15

1.34

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

1.87

1.34

1.1

—

16.67

—

(3025159) Blasts/Leukocytes in Blood

458

5034

0.90

1.34

4.3

4.7

0.03

0.33

1.78

107

1133

(3020630) Protein [Mass/volume] in Serum or Plasma

457

4156

1.11

1.31

2.3

2.6

67.00

66.68

g/l

0.46

402

3814

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

192

1651

1.17

1.31

2.0

2.1

190.66

523.59

ug/l

1.77

171

1526

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

177

1512

1.18

1.31

2.5

2.3

0.02

0.01

g/l

0.03

160

1362

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.84

1.29

1.0

0.02

0.17

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.35

1.29

1.0

1.2

6.38

14.81

pmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

395

1.34

1.28

1.5

11.00

22.59

u/ml

—

(3022475) Manganese [Moles/volume] in Blood

2.09

1.27

1.4

1.2

0.18

0.16

umol/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.00

1.27

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

642

1.27

1.26

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

913

1.22

1.25

1.3

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

447

4894

0.91

1.23

3.8

4.3

0.74

0.69

0.12

134

1310

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

293

2613

1.13

1.21

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

1.64

1.21

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

754

1.24

1.21

2.8

2.6

19.17

25.66

iu/ml

—

(3000012) Reticulocyte production index

604

0.74

1.19

1.3

2.1

0.84

0.91

0.26

367

(3009677) Dengue virus Ab [Presence] in Serum

2.31

1.18

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

1.60

1.17

1.1

1.2

—

(4198724) Urine methamphetamine measurement

240

1.42

1.15

3.2

2.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.05

1.15

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

367

3329

1.11

1.14

1.5

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.75

1.12

1.2

1.9

1.46

1.30

umol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

123

1038

1.19

1.09

1.9

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.38

1.09

1.4

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.82

1.08

2.4

2.5

2.60

3.95

ug/l

—

(3020491) Glucose [Moles/volume] in Blood

416

1.30

1.08

1.6

6.55

6.21

mmol/l

0.36

310

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

136

1.55

1.08

1.0

0.03

1.37

u/ml

—

(3029396) Erythrocyte agglutination [Presence] in Blood

269

1.38

1.08

2.5

3.2

—

(3011985) Renin [Units/volume] in Plasma

106

885

1.20

1.06

1.5

50.02

58.78

mu/l

0.31

794

(3020911) Cortisol [Moles/time] in 24 hour Urine

270

1.37

1.06

1.3

62.17

239.13

nmol/24h

0.88

270

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

153

1.51

1.06

1.1

1.3

14.83

17.85

pmol/l

0.57

136

(3012544) pH of Venous blood

494

4565

1.09

1.05

3.9

3.5

7.38

0.07

257

2542

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

645

6033

1.08

1.03

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

589

1.24

1.03

2.6

—

(3014271) Vancomycin [Susceptibility]

179

1.45

1.02

2.7

2.9

—

(4015189) Microbial culture of sputum

106

1.61

1.02

1.8

2.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

490

4537

1.09

1.01

3.9

3.5

5.90

5.81

kpa

1.21

480

4428

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

169

1475

1.15

1.01

1.4

4.94

3.65

ug/l

0.22

146

1309

(4027681) Cerebrospinal fluid IgG ratio and IgG index

421

1.29

1.01

1.2

0.64

0.63

ratio

0.00

246

(3025018) Bordetella pertussis Ab [Titer] in Serum

546

1.25

1.00

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

474

5118

0.92

1.00

3.9

4.5

0.90

0.91

0.03

140

1367

(44816559) Phosphatidylethanol [Mass/volume] in Blood

245

2194

1.12

0.99

1.6

0.32

0.28

mg/l

0.57

836

(3006442) Creatine [Moles/volume] in Serum or Plasma

326

1.32

0.98

1.7

1.4

67.26

70.50

umol/l

0.69

326

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

257

1.36

0.98

1.1

—

0.14

—

(40760409) HLA-A [Type] by High resolution

2.17

0.98

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.17

0.98

1.0

—

(40760410) HLA-B [Type] by High resolution

2.17

0.98

1.0

—

(40763590) HLA-DQ beta [Type]

2.17

0.98

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

459

1.27

0.97

1.8

1.5

304993.12

87456.32

e6/l

0.70

303

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

271

0.66

0.95

1.2

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

122

1421

0.86

0.95

3.0

3.7

1.17

1.32

mmol/l

1.55

122

1394

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

777

1.20

0.95

1.1

1.50

1.49

g/l

0.10

701

(3009508) Creatinine [Moles/volume] in Urine

1872

18114

1.05

0.95

3.5

3.3

6.78

6.79

mmol/l

0.03

1608

15376

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

943

0.83

0.93

1.4

7.57

6.97

mmol/l

1.18

840

(3024354) Oxygen [Partial pressure] in Venous blood

410

3783

1.09

0.93

3.1

3.0

4.66

4.55

kpa

0.49

400

3685

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

0.68

0.93

1.2

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.22

0.93

1.7

3.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

200

1.40

0.93

1.1

4.4

7378.95

60.44

mg/l

0.48

139

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.92

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

508

1.24

0.92

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

392

1.28

0.91

1.3

1.2

26.72

24.34

u/l

0.07

328

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

401

1.27

0.91

1.3

1.2

78.61

81.73

u/l

0.08

349

(4195642) Thrombophilia screening test

111

947

1.18

0.91

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

301

2742

1.10

0.91

8.3

8.7

24.38

24.35

mmol/l

0.07

291

2696

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

176

1.42

0.90

1.6

1.7

8.71

8.83

ug/l

0.07

176

(3021440) Promyelocytes/Leukocytes in Blood

457

4915

0.92

0.89

4.0

4.5

0.11

0.02

123

1168

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

290

0.69

0.89

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

367

1.28

0.89

1.3

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.07

0.89

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.91

0.88

1.3

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

228

1.36

0.88

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

316

1.30

0.86

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

195

1.39

0.86

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

195

1.39

0.86

2.1

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

230

2074

1.11

0.85

1.5

1.6

1.04

0.25

iu/ml

0.54

352

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

139

1216

1.15

0.84

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

231

1.34

0.82

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

231

1.34

0.82

1.4

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

141

0.57

0.82

4.1

2.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

607

1.20

0.82

1.3

1.4

33.84

36.52

nmol/l

0.26

552

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

197

1.37

0.81

2.1

1.8

—

(44813793) Dust mix specific IgE antibody measurement

517

1.22

0.81

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

117

1015

1.16

0.81

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

267

1.31

0.80

2.0

2.4

270.67

154.70

umol/l

0.59

147

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

538

5054

1.07

0.80

1.6

1024.50

1013.99

mu/l

0.10

449

4219

(21494890) Protein electrophoresis panel - 24 hour Urine

441

0.77

0.78

1.9

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

434

4051

1.08

0.78

2.5

2.6

66.58

71.21

e9/l

2.33

313

2896

(3011412) CD3 cells [#/volume] in Blood

556

1.21

0.78

2.8

2.3

1428.09

1242.97

e6/l

0.85

478

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

322

1.28

0.77

1.3

966.67

1040.74

titre

0.18

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

450

0.78

0.76

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

323

1.27

0.76

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.70

0.75

1.0

1.1

1.60

1.47

umol/24h

—

(3001556) Androgen free Index in Serum or Plasma

1.64

0.75

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

745

0.83

0.74

1.6

1.5

—

(3013862) HLA-DP [Type]

2.08

0.74

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.64

0.73

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

524

1.20

0.73

1.3

1.59

1.67

u/ml

0.03

283

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

0.72

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.80

0.72

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.61

0.72

1.1

117.33

80.00

titre

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

290

1.28

0.72

1.9

1.7

1.18

1.40

nmol/l

0.64

220

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.92

0.70

1.6

1.8

0.40

0.57

ug/l

—

(3026470) Cobalt [Mass/volume] in Blood

238

1.30

0.70

2.3

2.2

3.04

3.91

ug/l

0.45

220

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

587

0.82

0.70

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

107

1221

0.87

0.69

1.8

2.1

130.76

127.97

g/l

0.63

926

(3028717) Thiamine [Mass/volume] in Blood

1.51

0.69

1.3

1.2

61.79

62.08

ug/l

0.02

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.0

—

(3044941) Cell count panel - Synovial fluid

108

947

1.14

0.68

1.5

—

(3004451) EKG impression Narrative

250

0.72

0.67

1.8

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

196

1.33

0.67

2.9

1.9

0.17

0.19

e9/l

0.09

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

511

1.20

0.67

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

126

1118

1.13

0.66

1.3

133.80

154.78

au/ml

1.25

284

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

184

1669

1.11

0.66

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

197

1794

1.10

0.66

1.2

87.27

142.88

titre

0.83

160

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

167

0.66

0.65

1.0

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

406

0.79

0.65

1.9

2.0

1.86

2.15

u/field

0.11

209

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

375

3512

1.07

0.65

2.5

2.8

174.18

146.78

ng/l

0.64

337

3198

(40758292) HTLV I+II Ab panel - Serum

103

1.46

0.64

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

331

1.24

0.64

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

178

0.67

0.64

1.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

395

1.22

0.64

2.5

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

369

1.22

0.62

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

442

1.20

0.62

1.2

1.4

1819.19

2196.24

e6/l

0.44

298

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

173

1.33

0.61

3.6

2.5

0.59

0.61

mmol/l

0.84

173

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

217

1.29

0.61

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

106

1197

0.88

0.61

3.1

4.0

3.68

3.78

mmol/l

2.24

106

1188

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.46

0.61

1.1

1.2

—

0.33

—

(3037756) Immunofixation for Serum or Plasma

104

918

1.14

0.61

1.9

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

609

0.84

0.61

1.3

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.60

0.0

1.3

—

1.40

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.60

0.0

1.1

—

1.07

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

9370.40

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

109

967

1.13

0.60

1.1

121.26

119.43

0.24

101

862

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

218

1.29

0.60

2.0

2.2

52.95

50.13

umol/l

0.19

192

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

163

0.67

0.59

1.6

—

158.01

—

(3020891) Body temperature

196

2136

0.91

0.59

3.6

4.2

36.90

36.91

°c

0.26

196

2119

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3036603) Volume of Urine

418

1.20

0.58

1.7

1.5

2023.74

1959.33

0.20

411

(3018001) Oat IgE Ab [Units/volume] in Serum

1.56

0.58

1.0

0.04

0.27

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

166

1.33

0.58

1.2

1.5

6.83

7.40

mmol/l

0.21

166

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

149

1.34

0.57

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

114

1018

1.12

0.57

1.2

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

346

1.22

0.57

1.2

1.7

2.26

3.44

nmol/l

0.65

272

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

773

1.14

0.57

1.1

1.2

1.20

0.83

—

(3001729) Color of Synovial fluid

1.67

0.56

3.3

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

160

1457

1.10

0.56

2.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

582

0.84

0.56

1.2

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

208

2254

0.92

0.56

1.0

1.1

0.56

0.58

ratio

0.18

290

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

587

1.16

0.56

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

643

1.15

0.56

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

643

1.15

0.56

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

643

1.15

0.56

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

643

1.15

0.56

1.4

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

284

1.23

0.55

1.1

1.4

135.49

128.61

nmol/l

0.60

284

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

127

1407

0.90

0.55

3.7

3.1

2.09

2.45

ratio

0.30

803

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.58

0.54

1.0

1.1

—

(3012565) Volume of 24 hour Urine

284

0.77

0.54

1.7

1.9

1771.82

1852.11

0.17

263

(3021788) Differential panel - Synovial fluid

114

1023

1.12

0.53

1.6

—

1.00

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.48

0.53

1.0

—

(40768806) Pleura Pathology biopsy report

377

1.20

0.53

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

138

1255

1.10

0.51

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

179

1.29

0.51

2.5

3.0

28.70

26.86

umol/l

0.34

136

(3045142) Bone marrow Pathology biopsy report

537

1.16

0.50

1.2

1.4

—

(21494434) Karyotype in Bone marrow

361

1.19

0.50

1.1

1.2

—

(3024932) HLA-DR beta [Type]

127

1.34

0.49

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

234

1.24

0.49

2.2

2.3

3.00

3.11

ug/l

0.05

203

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

198

1836

1.08

0.49

2.9

3.4

4557.25

574.53

u/ml

0.60

159

1570

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.43

0.49

1.1

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

201

0.75

0.49

3.5

2.4

84.57

141.82

au/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

298

1.21

0.49

1.3

1.7

—

(3044007) Cell count panel - Peritoneal fluid

145

1.31

0.48

1.2

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

195

1809

1.08

0.48

1.3

1.2

504.00

851.23

titre

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.40

0.48

2.3

2.1

—

(3017569) Oxygen content in Arterial blood

222

0.77

0.47

1.5

2.3

15.89

15.79

0.05

222

(3004809) Band form neutrophils/Leukocytes in Blood

786

1.12

0.47

3.6

3.3

1.46

0.00

719

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

376

0.82

0.47

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.43

0.46

1.7

2.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

108

978

1.11

0.46

1.1

—

(3042517) Benzodiazepines panel - Urine

1.43

0.45

5.8

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

302

1.19

0.44

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

143

1317

1.09

0.43

1.5

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

104

1.35

0.43

1.9

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

586

0.87

0.43

1.3

2.1

32.12

32.08

0.02

581

(3041806) Other cells [#/volume] in Blood by Manual count

257

1.21

0.43

1.2

1.6

0.48

0.49

e9/l

0.08

257

(3044927) Protein electrophoresis panel - Urine

452

1.15

0.42

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.40

0.42

2.1

2.3

33.25

22.05

mg/l

—

(3045788) Cell count panel - Pleural fluid

378

1.17

0.42

1.2

1.4

—

(3024471) HLA-A [Type]

131

1.30

0.42

1.0

—

(3012441) Differential panel - Pleural fluid

369

1.17

0.41

1.2

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

167

1.26

0.41

1.0

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.41

0.0

1.1

—

67.59

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

0.02

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

0.14

—

(44806071) Cardiolipin IgM antibody measurement

105

1.33

0.41

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.41

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

123

1.30

0.40

1.0

1.3

5.62

5.12

nmol/l

0.26

116

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.47

0.40

4.6

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

1.26

0.40

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.40

0.0

1.2

—

5460.09

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

587

1.13

0.40

1.5

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.39

1.0

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

401

3839

1.05

0.39

5.9

6.9

7.68

8.59

mmol/l

2.54

382

3692

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

740

1.11

0.39

1.2

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

270.32

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

251

1.20

0.39

1.1

5.60

275.99

ng/l

—

(3034426) Prothrombin time (PT)

196

1.23

0.39

1.3

1.1

26.50

28.02

1.80

196

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

948

0.91

0.38

2.9

2.0

0.81

0.84

nmol/l

0.18

815

(3036048) Francisella tularensis Ab [Titer] in Serum

124

1.29

0.38

1.0

1.1

—

222.86

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.34

0.38

1.8

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

136

0.73

0.37

1.3

1.4

61.60

41.73

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

148

1589

0.93

0.37

3.6

3.3

44.90

76.32

mg/l

0.43

132

1354

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

0.12

2.32

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

152

1.25

0.37

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

1.27

0.36

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

172

1834

0.94

0.36

1.5

67.61

59.58

ug/l

1.63

172

1834

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

745

0.90

0.36

1.3

1.2

27.54

22.50

u/l

0.18

639

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

153

1.24

0.35

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

310

1.16

0.35

1.1

1.0

280.86

341.09

ng/l

0.76

226

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

135

1.26

0.35

2.2

4.2

4.76

4.87

kpa

0.28

135

(3028433) Virus identified in Specimen by Culture

172

1.22

0.34

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

265

0.83

0.34

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

154

1.23

0.33

1.1

32.78

33.28

iu/ml

0.01

154

(3018572) Chloride [Moles/volume] in Blood

918

0.91

0.33

6.4

6.8

105.72

105.23

mmol/l

0.38

819

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

1.25

0.33

2.2

4.1

10.74

10.42

kpa

0.24

136

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

149

1590

0.94

0.33

3.6

3.3

36.59

36.20

mg/l

0.02

134

1353

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

312

1.15

0.33

1.1

1.0

860.11

753.05

ng/l

0.58

218

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.30

0.33

1.2

1.1

0.02

0.37

u/ml

—

(3039000) Anion gap in Blood by calculation

917

0.91

0.33

6.4

6.8

10.58

11.01

mmol/l

0.91

817

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.28

0.32

4.3

6.0

9.70

10.23

—

(3024263) Appearance of Synovial fluid

229

1.18

0.32

1.8

—

(40765096) Chromosome analysis panel by Banding

137

1.24

0.32

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

896

1.08

0.31

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.32

0.30

3.9

11.3

5.80

4.93

mmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.72

0.30

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

142

0.77

0.30

1.3

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

138

1.23

0.30

1.2

1.9

1668.75

31292.25

e6/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

315

1.14

0.30

1.1

1.0

90.03

42.31

ng/l

0.43

229

(3000093) Morphology [Interpretation] in Blood Narrative

441

0.88

0.29

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

838

0.92

0.29

3.5

3.3

0.76

0.81

nmol/l

0.63

669

(40761539) Cells [Type] in Urine sediment by Light microscopy

111

0.72

0.28

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

119

0.76

0.27

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

224

1.16

0.27

1.3

1.9

7.10

8.25

mmol/l

1.12

224

(3000034) Microalbumin [Mass/volume] in Urine

416

0.89

0.26

2.3

2.8

7.25

39.15

mg/l

1.42

282

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

683

1.08

0.26

1.3

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.30

0.26

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

132

1.21

0.25

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

225

2156

1.05

0.25

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

1189

1.06

0.25

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

493

1.10

0.24

1.2

1.4

34.76

33.09

g/l

0.43

450

(3042631) Mycobacterium sp identified in Specimen

580

0.91

0.24

3.2

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.17

0.24

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

107

1006

1.06

0.24

1.6

1.4

63.17

63.42

mmol/l

0.02

812

(3002173) Hemoglobin [Mass/volume] in Arterial blood

427

4393

0.97

0.24

7.7

7.9

118.89

118.70

g/l

0.08

421

4286

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

600

1.08

0.23

1.3

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

456

4439

1.03

0.23

2.7

2.5

74.12

70.13

ml/min/173m2

1.57

186

1845

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.32

0.23

1.0

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

22.03

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

143

1.19

0.23

1.0

4.24

5.62

mg/g

1.64

138

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

323

1.12

0.22

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

928

0.94

0.22

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

221

0.86

0.22

1.8

2.0

8.58

9.81

mg/l

0.56

187

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

123

1297

0.95

0.22

3.2

0.34

0.38

iu/ml

0.56

717

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

582

5690

1.03

0.22

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.27

0.22

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

9.69

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

1.00

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.02

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

884

0.94

0.21

1.2

1.1

145.96

13470.02

iu/ml

0.60

193

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

34.93

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

479

1.09

0.20

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

176

1833

0.96

0.20

4.8

5.0

0.86

0.90

0.64

170

1729

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.0

—

10.90

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

145

1516

0.96

0.20

3.3

3.0

1.36

1.40

mg/l

0.38

133

1388

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

144

0.83

0.19

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.20

0.19

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

396

0.91

0.19

1.1

1922.36

1575.65

miu/ml

0.96

396

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

227

2195

1.04

0.19

3.4

3.5

49.76

47.54

0.73

222

2158

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

337

1.10

0.19

1.1

1.2

—

(40768441) Liver Pathology biopsy report

453

1.08

0.18

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

891

1.06

0.18

2.3

2.7

31.52

32.66

umol/l

0.16

808

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

195

0.87

0.17

4.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.15

0.17

1.0

1.1

—

5.06

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

195

1.13

0.17

2.7

154.41

158.90

nmol/l

0.09

175

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

268

0.90

0.17

1.6

1.8

1.74

2.54

u/field

0.45

183

(3016038) Potassium [Moles/volume] in Urine

368

1.09

0.17

1.4

1.2

32.09

33.49

mmol/l

0.17

325

(3020682) Albumin/Creatinine [Ratio] in Urine

1667

16512

1.01

0.17

3.9

4.0

6.49

7.94

mg/mmol

0.77

923

9355

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

173

1669

1.04

0.17

1.7

1.9

1.18

1.99

ug/l

1.16

147

1476

(1761482) Bacteria [#/volume] in Urine by Culture

102

1069

0.95

0.16

5.0

4.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

670

1.06

0.16

6.5

5.4

368.26

373.07

umol/l

0.09

584

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

292

1.10

0.16

1.0

93.67

90.82

0.23

223

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.13

0.16

3.9

8.0

4.65

5.53

kpa

—

(3017704) Immunofixation for Urine

216

1.11

0.15

1.8

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

448

1.07

0.15

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.21

0.15

1.2

1.1

—

35.48

—

(3007916) DNA double strand Ab [Titer] in Serum

1.21

0.15

1.2

1.4

—

260.21

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

829

1.05

0.15

1.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

597

6065

0.98

0.15

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

171

0.88

0.14

1.3

1.2

60.80

67.80

ug/l

0.16

171

(3027273) Bicarbonate [Moles/volume] in Venous blood

188

1937

0.97

0.14

3.8

2.9

25.58

25.43

mmol/l

0.25

183

1874

(3047189) Immunofixation for 24 hour Urine

202

0.89

0.14

2.4

1.8

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

314

1.08

0.14

1.3

1.2

10.71

9.96

mm/h

0.14

314

(3020650) Glucose [Presence] in Urine

218

1.10

0.13

1.8

0.00

0.03

estimate

0.80

218

(42529582) MDA5 Ab [Presence] in Serum by Line blot

180

0.89

0.13

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

180

0.89

0.13

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

180

0.89

0.13

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

180

0.89

0.13

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.17

0.13

1.2

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

143

1385

1.03

0.13

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

253

2586

0.98

0.12

9.4

8.9

15.77

15.72

0.11

248

2487

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

239

1.09

0.12

2.7

1.9

29.96

27.67

0.33

227

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

343

0.93

0.11

1.9

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

445

0.94

0.11

2.0

1.6

49.40

36.61

1.33

246

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

1381

1.03

0.11

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

163

1.10

0.10

1.3

2.1

430.09

984.68

e6/l

0.95

104

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

322

3166

1.02

0.10

7.0

7.3

24.94

24.90

mmol/l

0.07

322

3152

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.11

0.10

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

280

1.07

0.10

3.0

2.5

44.25

45.03

0.08

169

(3012516) Albumin [Mass/volume] in Urine

1640

16303

1.01

0.10

3.4

34.15

40.13

mg/l

0.64

927

9332

(3047181) Lactate [Moles/volume] in Blood

135

1386

0.97

0.10

5.1

5.6

1.38

1.22

mmol/l

0.72

127

1217

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

103

1061

0.97

0.09

1.5

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

274

2786

0.98

0.09

2.7

2.9

130.76

127.89

g/l

1.58

265

2710

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

448

1.05

0.09

2.4

1.9

15.57

14.10

0.47

435

(3002619) Bacteria identified in Specimen by Culture

155

1.10

0.09

1.0

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.07

0.08

1.0

—

(3021589) Normoblasts [#/volume] in Blood

2646

26364

1.01

0.08

9.7

10.6

0.00

e9/l

0.18

2068

21454

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.05

0.08

1.0

0.02

0.12

u/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

1.03

0.08

1.5

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.09

0.08

4.4

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.04

0.08

2.6

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

875

0.97

0.08

2.3

2.4

33.34

59.18

ug/min

1.14

509

(3006571) Granulocytes/Leukocytes in Synovial fluid

632

0.96

0.07

1.7

1.6

47.07

53.96

0.75

385

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.86

0.07

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

668

1.03

0.07

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.07

0.07

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.05

0.07

2.5

2.0

0.86

1.52

mg/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.05

0.07

4.0

7.7

5.61

5.81

kpa

—

(3009871) Measles virus Ab [Titer] in Serum

284

1.06

0.07

1.6

1.7

4434.29

3820.54

titre

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

163

0.92

0.07

1.1

—

60.20

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

197

2001

0.98

0.06

4.5

4.7

1.53

1.60

0.51

191

1885

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

987

1.02

0.06

1.2

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

532

1.03

0.06

5.7

4.5

7.53

6.97

mmol/l

0.52

440

(3019977) pH of Arterial blood

527

5312

0.99

0.06

7.1

7.2

7.42

0.15

270

2829

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

434

1.04

0.06

1.1

1.05

ratio

0.08

353

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

136

1384

0.98

0.06

1.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

236

2388

0.99

0.05

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

336

1.04

0.05

1.4

1.7

4.06

1.92

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

101

990

1.02

0.05

1.1

—

(3016502) Oxygen saturation in Arterial blood

457

4604

0.99

0.05

7.2

7.6

96.02

96.00

0.02

447

4443

(3035880) pH of Pleural fluid

181

0.94

0.05

1.1

1.2

7.43

7.42

—

117

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

1111

1.02

0.04

4.9

5.1

1001.80

496.19

iu/ml

—

127

(3027801) Oxygen [Partial pressure] in Arterial blood

528

5309

0.99

0.04

7.0

7.1

13.55

13.02

kpa

1.15

511

5106

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

190

1.05

0.04

1.1

2.1

—

7510.27

—

(3042733) HLA Ab [Presence] in Serum

131

1.07

0.03

3.0

4.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

1.07

0.03

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

305

3029

1.01

0.03

8.5

8.8

94.03

94.24

0.19

305

3018

(3052592) Norovirus Ag [Presence] in Stool

1.09

0.03

1.0

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

191

1.05

0.03

1.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4878

48748

1.00

0.03

19.0

17.2

13.43

13.52

6.74

4850

48139

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

529

5312

1.00

0.03

7.0

7.1

5.13

5.09

kpa

0.57

513

5116

(1761868) Lipid panel - Serum or Plasma

2374

23709

1.00

0.02

2.7

2.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

299

0.97

0.02

1.3

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

228

0.96

0.02

2.2

2.1

34.45

29.44

0.68

228

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.08

0.02

1.3

1.0

0.08

0.88

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

103

1038

0.99

0.01

3.0

3.6

62.71

764.25

u/ml

1.79

933

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

437

0.98

0.01

2.5

2.0

—

(4034850) Laboratory test

171

1718

1.00

0.01

10.8

9.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

104

1033

1.01

0.00

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

206

0.97

0.00

2.1

2.0

41.08

40.33

g/l

0.31

206

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

213

2123

1.00

0.00

1.7

1.53

1.54

g/l

0.06

185

1822

(3003396) Base excess in Arterial blood by calculation

527

5263

1.00

0.00

6.9

7.1

0.85

0.99

mmol/l

0.35

456

4366

(3000330) Specific gravity of Urine by Test strip

281

2804

1.00

0.00

3.4

3.2

1.02

ratio

0.51

231

2478

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

1.04

0.00

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

165

0.97

0.00

2.2

15.48

17.10

umol/l

0.19

165

(3020191) Ethanol [Moles/volume] in Serum or Plasma

388

1.01

0.00

1.3

1.5

1.23

1.08

promille

0.29

302

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1.03

0.00

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

345

0.99

0.00

1.2

1.1

33.20

17.24

u/ml

—

(4133840) Spirometry

124

0.97

0.00

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

176

1.02

0.00

3.9

3.3

1.03

1.56

0.67

176

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

177

1.02

0.00

3.3

3.4

33.11

84.21

ng/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

203

0.99

0.00

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

554

0.99

0.00

1.9

2.3

0.61

1.04

g/24h

1.42

308

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

19.20

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.99

0.00

3.4

2.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.80

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.98

0.00

1.8

2.4

1.00

0.77

u/field

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

298.40

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.98

0.00

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.94

-0.00

3.2

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.91

-0.00

1.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.13

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.87

-0.00

1.0

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.97

-0.00

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.90

-0.00

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.95

-0.00

1.5

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.00

-0.00

1.4

1.5

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.96

-0.00

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

-0.00

1.0

1.1

5.80

12.88

u/l

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

219.50

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

80.33

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

5.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.99

-0.00

1.4

1.3

5.61

5.71

mmol/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.91

-0.00

1.0

3.1

—

40.63

pmol/l

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_BREASTDISOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_BREASTDISOTH	1.077 [0.97, 1.19]	0.158
Birth year	1.0 [0.99, 1.01]	0.995

During the follow-up period (1.1.1998 — 31.12.2019), 1651 out of 19347 females with N14_BREASTDISOTH died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_BREASTDISOTH.

N-year risk	Females	Males
1	0.101%	No data
5	0.608%	No data
10	1.64%	No data
15	3.322%	No data
20	6.147%	No data

Relationships between endpoints

↥

Index endpoint: N14_BREASTDISOTH – Other disorders of breast

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints